TRANSAMERICA CORP
8-K, 1999-02-23
LIFE INSURANCE
Previous: SUNDSTRAND CORP /DE/, 8-K, 1999-02-23
Next: TULTEX CORP, 4, 1999-02-23




                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549



                               ------------------



                                    FORM 8-K


                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934




Date of Report (Date of earliest event reported):  February 17, 1999





                            TRANSAMERICA CORPORATION
              -----------------------------------------------------
               (Exact Name of Registrant as Specified in Charter)



    Delaware                          1-2964                      94-0932740  
 ----------------                  -----------               -------------------
  (State Or Other                  (Commission                 (IRS Employer
  Jurisdiction Of                  File Number)              Identification No.)
  Incorporation)




             600 Montgomery Street, San Francisco, California 94111
            ---------------------------------------------------------
               (Address of Principal Executive Offices) (Zip Code)




Registrant's telephone number, including area code        (415) 983-4000
                                                   -----------------------------
<PAGE>

ITEM 5.  OTHER EVENTS.

                  Transamerica Corporation, a Delaware corporation (the
"Company"), has entered into an Agreement and Plan of Merger and Reorganization,
dated as of February 17, 1999, by and among AEGON N.V. ("Aegon"), Tony Merger
Corp. ("Merger Sub") and the Company (the "Merger Agreement"), pursuant to
which, among other things, subject to the terms and conditions contained in the
Merger Agreement, the Company will be merged (the "Merger") into Merger Sub,
with Merger Sub surviving as a wholly owned subsidiary of Aegon, and each common
share of the Company will be converted into the right to receive $23.40 in cash
and $54.60 in Aegon common stock, par value of fifty cents Dutch Guilder ("Aegon
Common Stock"), subject to adjustment based upon the trading price of Aegon
Common Stock during the 20 trading day period ending one business day prior to
the closing of the Merger. The foregoing description of the Merger and the
Merger Agreement are qualified in their entirety by reference to the Merger
Agreement, which is filed as Exhibit 2.1 hereto and is incorporated herein by
reference. On February 18, 1999, the Company issued a joint press release with
Aegon announcing the execution of the Merger Agreement. A copy of the joint
press release is filed as Exhibit 99.1 hereto.


ITEM 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

Exhibit 2.1       Agreement and Plan of Merger and Reorganization, dated as of 
                  February 17, 1999, by and among AEGON N.V., Tony Merger Corp. 
                  and Transamerica Corporation

Exhibit 99.1      Joint Press Release dated February 18, 1999



<PAGE>

                                   SIGNATURES

                  Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.



                                        TRANSAMERICA CORPORATION




Date:  February 22, 1999                By:/s/ Burton E. Broome
                                           ---------------------------------
                                           Name:  Burton E. Broome
                                           Title: Vice Presidnet and Controller






<PAGE>

                                  EXHIBIT INDEX

Exhibit No.                Title
- -----------                -----

Exhibit 2.1       Agreement and Plan of Merger and Reorganization, dated as of 
                  February 17, 1999, by and among AEGON N.V., Tony Merger Corp. 
                  and Transamerica Corporation

Exhibit 99.1      Joint Press Release dated February 18, 1999






                                                                  EXECUTION COPY







- --------------------------------------------------------------------------------



                              AGREEMENT AND PLAN OF
                            MERGER AND REORGANIZATION

                                      AMONG

                                   AEGON N.V.,

                                TONY MERGER CORP.

                                       AND

                            TRANSAMERICA CORPORATION


- --------------------------------------------------------------------------------




                          -----------------------------
                                FEBRUARY 17, 1999
                          -----------------------------



<PAGE>



                                TABLE OF CONTENTS

ARTICLE 1

    PLAN OF MERGER.........................................................    1
    1.1    The Merger......................................................    1
    1.2    Conversion of Shares............................................    2
    1.3    Exchange of Certificates........................................    4
    1.4    Dividends.......................................................    6
    1.5    Escheat Laws....................................................    6
    1.6    Closing of Company Transfer Books...............................    6
    1.7    Withholding Rights..............................................    7
    1.8    Dissenting Shares...............................................    7
    1.9    Governance Matters..............................................    7

ARTICLE 2

    CLOSING................................................................    8
    2.1    Time and Place of Closing.......................................    8
                                                                               
ARTICLE 3                                                                      
                                                                               
    REPRESENTATIONS AND WARRANTIES OF COMPANY..............................    8
    3.1    Organization, Good Standing and Power...........................    8
    3.2    Capitalization..................................................    9
    3.3    Significant Subsidiaries........................................    9
    3.4    Authority; Enforceability.......................................   10
    3.5    Non-Contravention; Consents.....................................   10
    3.6    SEC Reports; Company Financial Statements.......................   11
    3.7    Statutory Statements............................................   12
    3.8    Absence of Certain Changes or Events............................   12
    3.9    Taxes and Tax Returns...........................................   13
    3.10   Litigation......................................................   15
    3.11   Contracts and Commitments.......................................   15
    3.12   Registration Statement, Etc.....................................   15
    3.13   Employee Benefit Plans..........................................   16
    3.14   Labor Matters...................................................   18
    3.15   Brokers and Finders.............................................   18
    3.16   No Violation of Law.............................................   18
    3.17   Environmental Matters...........................................   19
    3.18   Fairness Opinion................................................   20
    3.19   Certain Approvals...............................................   20
    3.20   Merger..........................................................   20
    3.21   Voting Requirements.............................................   20

                                       i
<PAGE>

    3.22   Computer Software/Year 2000.....................................   20
    3.23   Intellectual Property...........................................   21
    3.24   Separate Accounts...............................................   21
    3.25   Funds...........................................................   22
    3.26   Insurance.......................................................   22
                                                                              
ARTICLE 4                                                                     
                                                                              
    REPRESENTATIONS AND WARRANTIES OF MERGER PARTNER AND SUB...............   22
    4.1    Organization, Good Standing and Power...........................   22
    4.2    Capitalization..................................................   23
    4.3    Merger Partner Significant Subsidiaries.........................   24
    4.4    Authority; Enforceability.......................................   24
    4.5    Non-Contravention; Consents.....................................   24
    4.6    SEC Reports; Merger Partner Financial Statements................   26
    4.7    Statutory Statements............................................   26
    4.8    Absence of Certain Changes or Events............................   27
    4.9    Taxes and Tax Returns...........................................   27
    4.10   Litigation......................................................   28
    4.11   Contracts and Commitments.......................................   28
    4.12   Registration Statement, Etc.....................................   28
    4.13   Employee Benefit Plans..........................................   29
    4.14   Labor Matters...................................................   31
    4.15   Brokers and Finders.............................................   31
    4.16   No Violation of Law.............................................   31
    4.17   Environmental Matters...........................................   32
    4.18   Interim Operations of Sub.......................................   33
    4.19   Merger..........................................................   33
    4.20   Computer Software/Year 2000.....................................   33
    4.21   Intellectual Property...........................................   33
    4.22   Insurance.......................................................   34
    4.23   Affiliate Transactions..........................................   34
                                                                              
ARTICLE 5                                                                     
                                                                              
    CONDUCT AND TRANSACTIONS PRIOR TO                                         
    EFFECTIVE TIME; CERTAIN COVENANTS......................................   34
    5.1    Access and Information..........................................   34
    5.2    Conduct of Business Pending Merger..............................   35
    5.3    Fiduciary Duties................................................   42
    5.4    Certain Fees....................................................   43
    5.5    Takeover Statutes...............................................   43
    5.6    Consents........................................................   43
    5.7    Further Assurances..............................................   44

                                       ii
<PAGE>

    5.8    NYSE Listing....................................................   44
    5.9    Notice; Efforts to Remedy.......................................   44
    5.10   Registration Statement; Stockholder Approvals...................   45
    5.11   Expenses........................................................   45
    5.12   Press Releases; Filings.........................................   46
    5.13   Indemnification of Officers and Directors.......................   46
    5.14   Tax Treatment...................................................   47
    5.15   Employee Benefits...............................................   48
    5.16   Equity-Based Awards.............................................   48
    5.17   Rule 145........................................................   50
    5.18   Comfort Letters.................................................   50
    5.19   Y2K Plans.......................................................   50
    5.20   Compliance with 1940 Act........................................   50
                                                                              
ARTICLE 6                                                                     
                                                                              
    CONDITIONS PRECEDENT TO MERGER.........................................   51
    6.1    Conditions to Each Party's Obligations..........................   51
    6.2    Conditions to Obligations of Company............................   52
    6.3    Conditions to Obligations of Merger Partner.....................   53
                                                                              
ARTICLE 7                                                                     
                                                                              
    TERMINATION AND ABANDONMENT OF THE MERGER..............................   54
    7.1    Termination.....................................................   54
    7.2    Effect of Termination and Abandonment...........................   55
                                                                              
ARTICLE 8                                                                     
                                                                              
    MISCELLANEOUS..........................................................   56
    8.1    Waiver and Amendment............................................   56
    8.2    Non-Survival of Representations; Warranties and Agreements......   56
    8.3    Notices.........................................................   56
    8.4    Descriptive Headings; Interpretation............................   58
    8.5    Counterparts....................................................   58
    8.6    Entire Agreement................................................   58
    8.7    GOVERNING LAW...................................................   59
    8.8    Severability....................................................   59
    8.9    Enforcement of Agreement........................................   59
    8.10   Assignment......................................................   59
    8.11   Obligation of Merger Partner....................................   59
    8.12   CONSENT TO JURISDICTION; SERVICE OF PROCESS.....................   60

                                      iii
<PAGE>
                                                                              
ARTICLE 9                                                                     
                                                                              
    DEFINITIONS............................................................   61
    9.1    Definitions.....................................................   61
    9.2    Certain Defined Terms Index.....................................   62
                                                                           

ANNEX A - EXCHANGE RATIO COMPUTATION EXAMPLES





















                                       iv
<PAGE>

                              AGREEMENT AND PLAN OF
                            MERGER AND REORGANIZATION


         AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this "Agreement")
dated as of February 17, 1999, by and among AEGON N.V., a company formed under
the laws of The Netherlands ("Merger Partner"), Tony Merger Corp., a Delaware
corporation and a direct wholly owned subsidiary of Merger Partner ("Sub"), and
Transamerica Corporation, a Delaware corporation ("Company").

         WHEREAS, Merger Partner has formed Sub as a direct wholly owned
subsidiary corporation under the Delaware General Corporation Law (the "DGCL")
for the purpose of Company merging with and into Sub pursuant to the applicable
provisions of the DGCL (the "Merger") so that Sub will continue as the surviving
corporation of the Merger and will remain a direct wholly owned subsidiary of
Merger Partner;

         WHEREAS, the Boards of Directors of each of Company and Sub, and the
Supervisory and Executive Boards of Merger Partner have approved and declared
advisable the Merger, the terms and provisions of this Agreement and the
transactions contemplated hereby;

         WHEREAS, the Boards of Directors of each of Company and Sub, and the
Supervisory and Executive Boards of Merger Partner have determined that the
Merger is fair to and in the best interests of their respective stockholders;

         WHEREAS, for federal income tax purposes, it is intended that the
Merger shall qualify as a reorganization within the meaning of Section 368(a) of
the Code, and this Agreement is intended to be and is adopted as a plan of
reorganization; and

         WHEREAS, the Merger described herein is subject to the approval of the
stockholders of Company and applicable state, federal and foreign authorities,
and satisfaction of certain other conditions described in this Agreement.

         NOW, THEREFORE, in consideration of the premises and of the mutual
representations, warranties, covenants and agreements herein contained, the
parties agree as follows:

                                    ARTICLE 1

                                 PLAN OF MERGER

         1.1 The Merger.

                  (a) Upon the terms and subject to the conditions of this
Agreement, at the Effective Time and in accordance with the provisions of this
Agreement and the DGCL, Company shall be merged with and into Sub, which shall
be the surviving corporation (sometimes referred to hereinafter as the
"Surviving Corporation") in the Merger, and the separate corporate existence of
Company shall cease. Subject to the provisions of this Agreement, on the Closing
Date (as defined in Section 2.1) a certificate of merger (the "Certificate of
Merger") shall be duly pre-

                                       1
<PAGE>

pared, executed and acknowledged by Sub, on behalf of the Surviving Corporation,
and immediately thereafter delivered to the Secretary of State of the State of
Delaware, for filing, as provided in the DGCL. The Merger shall become effective
upon the filing of the Certificate of Merger with the Secretary of State of the
State of Delaware (the "Effective Time").

                  (b) From and after the Effective Time, the Merger shall have
all the effects set forth in the DGCL. Without limiting the generality of the
foregoing, and subject thereto, by virtue of the Merger and in accordance with
the DGCL, all of the properties, rights, privileges, powers and franchises of
Company and Sub shall vest in the Surviving Corporation and all of the debts,
liabilities and duties of Company and Sub shall become the debts, liabilities
and duties of the Surviving Corporation.

                  (c) The Certificate of Incorporation of Sub shall be amended
to change the name of Sub to the name of Company and, as so amended, shall be
the Certificate of Incorporation of the Surviving Corporation until thereafter
amended in accordance with the provisions thereof and the DGCL.

                  (d) The Bylaws of Sub in effect immediately prior to the
Effective Time shall be the Bylaws of the Surviving Corporation until altered,
amended or repealed as provided therein or in the Certificate of Incorporation
of the Surviving Corporation and the DGCL.

                  (e) The officers and directors of Sub immediately prior to the
Effective Time shall be the initial officers and directors of the Surviving
Corporation, in each case until their respective successors are duly elected and
qualified.

         1.2 Conversion of Shares. As of the Effective Time, by virtue of the
Merger and without any action on the part of any holder thereof:

                  (a) Each share of capital stock of Sub that is issued and
outstanding immediately prior to the Effective Time shall remain outstanding
unchanged by reason of the Merger as one fully paid and nonassessable share of
Common Stock, no par value per share, of the Surviving Corporation.

                  (b) All shares of common stock, par value $1 per share, of
Company ("Company Common Stock") (or other capital stock of Company), that are
owned by Company as treasury stock or by any wholly owned Subsidiary of Company
and any shares of Company Common Stock owned by Merger Partner, Sub or any other
wholly owned Subsidiary of Merger Partner shall be canceled and retired and
shall cease to exist and no stock of Merger Partner or other consideration shall
be delivered in exchange therefor.

                  (c) Subject to Section 1.3(c), each share of Company Common
Stock that is issued and outstanding immediately prior to the Effective Time
(other than shares to be canceled in accordance with Section 1.2(b) and
Dissenting Shares) shall be converted into a right to receive (i) $23.40 in cash
(the "Cash Payment") plus (ii) the number of shares, or fraction thereof, of
voting common stock, par value of fifty cents (0.50) Dutch Guilder per share, of
Merger Partner ("Merger Partner Common Stock") equal to the Exchange Ratio (as
defined below). All such 


                                       2
<PAGE>

shares of Company Common Stock, when so converted, shall no longer be
outstanding and shall automatically be canceled and retired and shall cease to
exist, and each certificate previously representing any such shares (a
"Certificate") shall thereafter represent the right to receive that amount of
Cash Payment and that number of shares of Merger Partner Common Stock into which
such shares of Company Common Stock have been converted. Certificates previously
representing shares of Company Common Stock shall be exchanged for the Cash
Payment and certificates representing whole shares of Merger Partner Common
Stock, and cash in lieu of any fractional share, issued in consideration
therefor upon the surrender of such certificates in accordance with Section 1.3,
without interest. For purposes of this Agreement:

         (i)    "Initial Price" shall mean $95.20;

         (ii)   "Stock Consideration Amount" shall mean $54.60;

         (iii)  "Share Price" shall equal the average during the 20 trading days
                immediately preceding the last business day before the date of
                the Effective Time of the closing price per share of Merger
                Partner Common Stock in Euros on the Amsterdam Stock Exchange
                ("ASE") as so reported in the Financial Times or, if not
                reported therein, another authoritative source (converting each
                of such daily closing prices per share to U.S. Dollars based
                upon the "closing mid-point" exchange rate published in respect
                of each such trading day in the "Currency and Money" segment in
                the "Companies & Markets" section of the Financial Times);

         (iv)   "Percentage Price Change" shall mean the quotient (whether a
                positive or negative amount) obtained by dividing (A) the
                difference obtained by subtracting (x) the Initial Price from
                (y) the Share Price, by (B) the Initial Price;

         (v)    "Excess Change Amount" shall mean the difference (whether a
                positive or negative amount) obtained by (A) subtracting 0.2 (in
                case of a Share Price greater than the Initial Price) from, or
                (B) adding 0.2 (in case of a Share Price less than the Initial
                Price) to, the Percentage Price Change;

         (vi)   "Adjusted Stock Consideration Amount" shall mean the sum of the
                Stock Consideration Amount and 1/2 of the product obtained by
                multiplying the Stock Consideration Amount by the Excess Change
                Amount;

         (vii)  "Exchange Ratio" shall equal that number of shares, or fraction
                thereof, determined as follows (rounded to the nearest hundred
                thousandth of a share):

                           (A)      if the Share Price is greater than or equal
                                    to $76.16 but less than or equal to $114.24,
                                    the quotient obtained by dividing (x) the
                                    Stock Consideration Amount by (y) the Share
                                    Price,

                           (B)      if the Share Price is less than or equal to
                                    $128.52 but greater than $114.24, the
                                    quotient obtained by dividing (x) the
                                    Adjusted Stock Consideration Amount by (y)
                                    the Share Price,

                                       3
<PAGE>

                           (C)      if the Share Price is greater than $128.52,
                                    0.45670 or the number, if any, determined
                                    pursuant to Section 7.1(c)(vi),

                           (D)      if the Share Price is greater than or equal
                                    to $61.88 but less than $76.16, the quotient
                                    obtained by dividing (x) the Adjusted Stock
                                    Consideration Amount, by (y) the Share
                                    Price, and

                           (E)      if the Share Price is less than $61.88, 
                                    0.81618 or the number, if any, determined 
                                    pursuant to Section 7.1(b)(vi).

                  Annex A hereto sets forth examples of the calculation of the
Exchange Ratio.

                  (d) If after the date hereof and prior to the Effective Time,
Merger Partner shall have declared a stock split (including a reverse split) of
Merger Partner Common Stock or a dividend payable in Merger Partner Common Stock
or any other similar transaction, then the Cash Payment and the Exchange Ratio
shall be appropriately adjusted to reflect such stock split or dividend or
similar transaction.

                  (e) Each Option (as defined in Section 5.16), TLSAR (as
defined in Section 5.16) and Stock Award (as defined in Section 5.16) shall be
converted into the right to receive cash in accordance with Section 5.16.

         1.3 Exchange of Certificates.

                  (a) Immediately prior to the Effective Time, Merger Partner or
Sub shall deposit with Citibank N.A., or such other bank or trust company
designated by Merger Partner and reasonably acceptable to Company (the "Exchange
Agent"), for the benefit of the holders of shares of Company Common Stock,
Options, TLSARs and Stock Awards, for exchange in accordance with this Article 1
through the Exchange Agent, in the aggregate, (i) cash in respect of the Cash
Payment for each share of Company Common Stock payable pursuant to Section 1.2,
(ii) certificates representing the shares of Merger Partner Common Stock
issuable pursuant to Section 1.2, (iii) any additional cash to be paid in lieu
of fractional shares, and (iv) except to the extent that Company and Merger
Partner otherwise agree, cash payable pursuant to Section 5.16 in respect of
Options, TLSARs and Stock Awards (such shares of Merger Partner Common Stock,
together with any dividends or distributions with respect thereto and cash
deposited by Merger Partner in accordance with this Section 1.3, being
hereinafter referred to as the "Exchange Fund"). The aggregate number of shares
of Merger Partner Common Stock which shall be issuable shall be a number of such
shares equal to the Exchange Ratio multiplied by the total number of outstanding
shares of Company Common Stock as of the Effective Time (including shares of
Restricted Stock), subject to adjustments for nonissuance of fractional shares
as provided herein.

                  (b) As soon as practicable after the Effective Time but in no
event more than two business days following the Closing Date, Merger Partner and
the Surviving Corporation shall cause the Exchange Agent to mail to each holder
of record of a Certificate or Certificates (and appropriate documentation for
holders of Options, TLSARs and Stock Awards) (i) a letter 


                                       4
<PAGE>

of transmittal (which shall specify that delivery shall be effected, and risk of
loss and title to the Certificates shall pass, only upon delivery of the
Certificates to the Exchange Agent accompanied by a properly executed letter of
transmittal and shall be in such form and have such other provisions as Merger
Partner and Company may reasonably specify), and (ii) instructions for use in
effecting the surrender of the Certificates in exchange for cash and
certificates representing shares of Merger Partner Common Stock. Upon the
surrender to the Exchange Agent of one or more Certificates for cancellation,
together with such letter of transmittal, duly executed, the holder will be
entitled to receive (i) an amount in cash determined by multiplying (x) the Cash
Payment amount by (y) the aggregate number of such shares of Company Common
Stock previously represented by the stock certificates surrendered, (ii)
certificates representing that number of whole shares of Merger Partner Common
Stock to be issued in respect of the aggregate number of such shares of Company
Common Stock previously represented by the stock certificates surrendered based
upon the Exchange Ratio and (iii) an additional amount of cash in lieu of any
fractional share, as contemplated by Section 1.2(c). Upon the delivery to the
Exchange Agent of the appropriate documentation in respect of Options, TLSARs or
Stock Awards, the holder of such Options, TLSARs or Stock Awards will be
entitled to receive an amount in cash determined pursuant to Section 5.16.

                  (c) No certificate or scrip representing fractional shares of
Merger Partner Common Stock shall be issued upon the surrender for exchange of
Certificates, and such fractional share interests will not entitle the owner
thereof to vote or to any rights as a stockholder of Merger Partner. All
fractional shares of Merger Partner Common Stock that a holder of Company Common
Stock would otherwise be entitled to receive as a result of the Merger shall be
aggregated and if a fractional share results from such aggregation, such holder
shall be entitled to receive, in lieu thereof, an amount in cash determined by
multiplying (i) the Share Price at the Effective Time of one share of Merger
Partner Common Stock by (ii) the fraction of a share of Merger Partner Common
Stock to which such holder would otherwise have been entitled. Merger Partner
shall timely make available to the Exchange Agent any cash necessary to make
payments in lieu of fractional shares as aforesaid. No such cash in lieu of
fractional shares of Merger Partner Common Stock shall be paid to any holder of
Company Common Stock until Certificates are surrendered and exchanged in
accordance with Section 1.3(a).

                  (d) If a certificate for Merger Partner Common Stock is to be
sent to a person other than the person in whose name the Certificates for shares
of Company Common Stock surrendered for exchange are registered, it shall be a
condition of the exchange that the person requesting such exchange shall pay to
the Exchange Agent any transfer or other taxes required by reason of the
delivery of such Certificate to a person other than the registered holder of the
Certificate surrendered, or shall establish to the satisfaction of the Exchange
Agent that such tax has been paid or is not applicable.

                  (e) The Cash Payments made and the shares of Merger Partner
Common Stock issued upon the surrender of Certificates in accordance with the
terms hereof shall be deemed to have been paid and issued in full satisfaction
of all rights pertaining to such shares of Company Common Stock.

                                       5
<PAGE>

                  (f) In the event any Certificate shall have been lost, stolen
or destroyed, upon the making of an affidavit of that fact by the person
claiming such Certificate to be lost, stolen or destroyed and, if required by
the Surviving Corporation, the posting by such person of a bond in such
reasonable amount as the Surviving Corporation may direct as indemnity against
any claim that may be made against it with respect to such Certificate, the
Exchange Agent will issue in exchange for such lost, stolen or destroyed
Certificate the Cash Payments and shares of Merger Partner Common Stock and cash
in lieu of fractional shares, and unpaid dividends and distributions on shares
of Merger Partner Common Stock as provided in this Section 1.3, deliverable in
respect thereof pursuant to this Agreement.

         1.4 Dividends. No dividends or other distributions that are declared or
made after the Effective Time with respect to Merger Partner Common Stock and
payable to holders of record thereof after the Effective Time shall be paid to a
Company stockholder entitled to receive certificates representing Merger Partner
Common Stock until such stockholder has properly surrendered such stockholder's
Certificates. Upon such surrender, there shall be paid to the stockholder in
whose name the certificates representing such Merger Partner Common Stock shall
be issued any dividends or other distributions with a record date after the
Effective Time payable with respect to such Merger Partner Common Stock and not
paid, without interest. After such surrender, there shall also be paid to the
stockholder in whose name the certificates representing such Merger Partner
Common Stock shall be issued any dividend or other distributions on such Merger
Partner Common Stock that shall have a record date subsequent to the Effective
Time and prior to such surrender and a payment date after such surrender;
provided that such dividend payments or other distributions shall be made on
such payment dates. In no event shall the stockholders entitled to receive such
dividends or other distributions be entitled to receive interest on such
dividends or other distributions. Any portion of the Exchange Fund which remains
undistributed to the stockholders of Company for one year after the Effective
Time pursuant to this Section 1.4 shall be returned by the Exchange Agent to
Merger Partner which shall thereafter act as Exchange Agent, subject to the
rights of holders of unsurrendered Certificates under this Article 1.

         1.5 Escheat Laws. Notwithstanding any other provision of this Article
1, none of Merger Partner, Sub, Company, the Surviving Corporation, the Exchange
Agent or any other party hereto shall be liable to any holder of Company Common
Stock for any amount of Cash Payment or Merger Partner Common Stock, or
dividends or distributions thereon, or cash in lieu of fractional shares,
delivered to a public official pursuant to any applicable abandoned property,
escheat or similar laws.

         1.6 Closing of Company Transfer Books. At the Effective Time, the stock
transfer books of Company shall be closed and no transfer of Company Common
Stock shall thereafter be made. If, after the Effective Time, Certificates are
presented to the Surviving Corporation, they shall, when accompanied by proper
documentation, be exchanged for the Cash Payment and Merger Partner Common Stock
in the manner provided in this Article 1.

         1.7 Withholding Rights. The Surviving Corporation or the Merger
Partner, as the case may be, shall be entitled to deduct and withhold from the
consideration otherwise payable pursu-


                                       6
<PAGE>

ant to this Agreement to any person such amounts as it is required to deduct and
withhold with respect to the making of such payment under the Internal Revenue
Code of 1986, as amended (the "Code"), or any provision of state or local tax
law. To the extent that amounts are so withheld by the Surviving Corporation or
Merger Partner, as the case may be, such amounts withheld shall be treated for
purposes of this Agreement as having been paid to such person in respect of
which such deduction and withholding was made by the Surviving Corporation or
Merger Partner as the case may be.

         1.8 Dissenting Shares. Notwithstanding anything to the contrary
contained in this Agreement, shares of Company Common Stock outstanding
immediately prior to the Effective Time held by a holder (if any) who shall be
entitled to demand, and who properly demands, appraisal for such shares in
accordance with Section 262 of the DGCL ("Dissenting Shares"), shall not be
converted into the right to receive the consideration to which such holder would
otherwise have been entitled pursuant to Section 1.2, unless and until such
holder shall have failed to perfect or withdrawn or lost such holder's rights
under Section 262 of the DGCL, and shall be entitled to receive only such
payment provided for by Section 262 of the DGCL.

         1.9 Governance Matters. Following the date hereof and prior to the
Effective Time, the Supervisory Board of Merger Partner shall take such action
as necessary so that immediately following the Effective Time, Frank C.
Herringer is elected or appointed as a member of the Executive Board of Merger
Partner and as Chairman of AEGON USA, Inc. ("AEGON USA") and the Surviving
Corporation. Donald Shepard shall be elected or appointed as President and Chief
Executive Officer of the Surviving Corporation and shall continue to serve as
President and Chief Executive Officer of AEGON USA. Following the Effective
Time, the headquarters of the Surviving Corporation and AEGON USA shall be in
San Francisco. At or prior to the Effective Time, the Supervisory Board of
Merger Partner will take such action as may be necessary to invite, and if such
invitation is accepted, cause the appointment of one, or in Merger Partner's
discretion, two, current directors of Company as ex officio members of the
Supervisory Board immediately following the Effective Time and at the next
meeting of Merger Partner's stockholders use best efforts to cause the election
or appointment of such person(s) as full members of the Supervisory Board.

                                    ARTICLE 2

                                     CLOSING

         2.1 Time and Place of Closing. Unless otherwise mutually agreed upon
in writing by Merger Partner and Company, the closing of the Merger (the
"Closing") will be held at 10:00 a.m., local time, on the third business day
following the date that all of the conditions precedent specified in this
Agreement have been (or can be at the Closing) satisfied or waived by the party
or parties permitted to do so (such date being referred to hereinafter as the
"Closing Date"). The place of Closing shall be at the offices of LeBoeuf, Lamb,
Greene & MacRae, L.L.P., 125 West 55th Street, New York, New York 10019, or at
such other place as may be agreed between Merger Partner and Company.


                                       7
<PAGE>

                                    ARTICLE 3

                               REPRESENTATIONS AND
                              WARRANTIES OF COMPANY

         Except as set forth in the disclosure letter delivered to Merger
Partner concurrent with the execution hereof (the "Company Disclosure Letter")
or the Company Supplemental Disclosure Letter (as defined below) or as disclosed
in the Company Reports (as defined below) filed prior to the date hereof,
Company hereby represents and warrants to Merger Partner as follows:

         3.1 Organization, Good Standing and Power.

                  (a) Company is a corporation duly organized, validly existing
and in good standing under the laws of the State of Delaware and has all
requisite corporate power and authority to own, lease and operate its properties
and to carry on its business as now being conducted. Company is duly qualified
or licensed to do business and is in good standing in each jurisdiction in which
the nature of its business or the ownership or leasing of its properties make
such qualification or licensing necessary, except where the failure to be so
qualified or licensed or to be in good standing would not, individually or in
the aggregate, have a Material Adverse Effect on Company. Company has made
available to Merger Partner complete and correct copies of its Restated
Certificate of Incorporation as in effect as of the date hereof and its Bylaws
as amended to the date hereof. As used in this Agreement, the phrase "Material
Adverse Effect on Company" means a material adverse effect on (a) on a
consolidated basis, the financial condition, business or the annual earnings
capacity of Company and the Subsidiaries of Company (the "Company
Subsidiaries"), except to the extent that such adverse effect results from
general economic conditions or changes therein, financial market fluctuations or
conditions, adverse changes or effects in or affecting the financial services or
insurance industries generally, or as a consequence of the transactions
contemplated herein (including, without limitation, the announcement thereof),
or (b) the ability of Company to consummate the transactions contemplated by
this Agreement.

                  (b) Each Company Subsidiary is an entity duly organized,
validly existing and in good standing (where such concept exists) under the laws
of its jurisdiction of organization, and has the corporate (or, if not a
corporation, other) power and authority necessary for it to own or lease its
properties and assets and to carry on its business as it is now being conducted,
except where the failure to be so organized, existing or in good standing (where
such concept exists) or to have such power and authority would not, individually
or in the aggregate, have a Material Adverse Effect on Company. Each Company
Subsidiary is duly qualified or licensed to do business and is in good standing
in each jurisdiction in which the nature of its business or the ownership or
leasing of its properties makes such qualification or licensing necessary,
except where the failure to be so qualified or licensed or to be in good
standing would not, individually or in the aggregate, have a Material Adverse
Effect on Company.

         3.2 Capitalization. The authorized capital stock of Company as of the
date hereof consists of (i) 300 million shares of Common Stock, par value $1 per
share, of which as of February 


                                       8
<PAGE>

12, 1999, 124,549,157 shares were issued and outstanding and 29,260,350 shares
of Company Common Stock were reserved for issuance upon exercise of outstanding
Options (as defined below), (ii) 5 million shares of preference stock, without
par value, of which as of the date hereof no shares are issued and outstanding,
and (iii) 1,200,000 shares of Preferred Stock, par value $100 per share, of
which as of the date hereof no shares are issued and outstanding. All
outstanding shares of Company Common Stock are, and all shares which may be
issued prior to the Effective Time pursuant to any outstanding Options will be,
when issued, duly authorized, validly issued, fully paid and nonassessable and
not subject to any preemptive rights. Except as set forth above, as of February
12, 1999, there were no shares of capital stock of Company outstanding, and,
except as set forth in Schedule 3.2 of the Company Disclosure Letter, as of
February 12, 1999 there are no outstanding options, warrants or rights to
purchase or acquire from Company any capital stock of Company, there are no
existing registration covenants with Company with respect to outstanding shares
of Company Common Stock, and there are no convertible securities or other
contracts, commitments, agreements, understandings, arrangements or restrictions
by which Company is bound to issue any additional shares of its capital stock.

         3.3 Significant Subsidiaries. For purposes of this Agreement,
"Significant Subsidiary" shall mean significant subsidiary as defined in Rule
1-02 of Regulation S-X of the Exchange Act. Except as would not have a Material
Adverse Effect on Company or as disclosed in the Company Disclosure Letter, (i)
Company owns, directly or indirectly, the securities of each Significant
Subsidiary held by Company, free and clear of all liens, charges, pledges,
security interests or other encumbrances, and (ii) all of the outstanding
capital stock of each Significant Subsidiary has been duly authorized, and is
validly issued, fully paid and nonassessable. There are no outstanding options
or rights to subscribe to, or any contracts or commitments to issue or sell any
shares of the capital stock or any securities or obligations convertible into or
exchangeable for, or giving any person any right to acquire, any shares of the
capital stock of any Significant Subsidiary to which Company or any Significant
Subsidiary is a party. There are no voting trusts or other agreements with
respect to the voting of capital stock of Company or any Significant Subsidiary
to which Company or any Significant Subsidiary is a party. Schedule 3.3 to the
Company Disclosure Letter sets forth for each Significant Subsidiary of Company,
its name and jurisdiction of incorporation or organization.

         3.4 Authority; Enforceability. Company has the corporate power and
authority to enter into this Agreement and to consummate the transactions
contemplated hereby. The execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby have been duly authorized
by all necessary corporate action on the part of Company other than the approval
and adoption of this Agreement by the Company's stockholders, and this Agreement
has been duly executed and delivered by Company and constitutes the valid and
binding obligation of Company, enforceable against it in accordance with its
terms, (i) except as may be limited by bankruptcy, insolvency, moratorium or
other similar laws affecting or relating to enforcement of creditors' rights
generally and (ii) subject to general principles of equity.

                                       9
<PAGE>

         3.5 Non-Contravention; Consents.

                  (a) Except as would not have a Material Adverse Effect on
Company, neither the execution, delivery and performance by Company of this
Agreement, nor the consummation by Company of the transactions contemplated
hereby, nor compliance by Company with any of the provisions hereof, will:

                  (i) violate, conflict with, result in a breach of any
         provision of, constitute a default (or an event that, with notice or
         lapse of time or both, would constitute a default) under, result in the
         termination of, accelerate the performance required by, or result in a
         right of termination or acceleration, or the creation of any lien,
         security interest, charge or encumbrance upon any of the properties or
         assets of Company, under any of the terms, conditions or provisions of,
         (x) its Certificate of Incorporation or Bylaws, or (y) any note, bond,
         mortgage, indenture, deed of trust, license, lease, contract, agreement
         or other instrument or obligation to which Company or any of the
         Company Subsidiaries is a party, or by which Company or any of the
         Company Subsidiaries may be bound, or to which Company or any of the
         Company Subsidiaries or the properties or assets of any of them may be
         subject (any of the foregoing being referred to herein as a
         "Violation"); or

                  (ii) subject to compliance with the statutes and regulations
         referred to in Section 3.5(b), violate any valid and enforceable
         judgment, ruling, order, writ, injunction, decree, or any statute, rule
         or regulation applicable to Company or any of the Company Subsidiaries
         or any of their respective properties or assets.

                  (b) Except for (i) the filing of applications and notices, as
applicable, with federal and state regulatory authorities governing banking,
insurance premium finance, commercial collections, broker-dealers, investment
advisors and investment companies, leasing, consumer finance, commercial
finance, mortgage lending and insurance in the states in which Company and the
Company Subsidiaries operate their respective business and the approval of such
applications or the grant of required licenses by such authorities, (ii) the
filing of applications and notices, as applicable, with the foreign governmental
authorities regulating banking, insurance premium finance, commercial
collections, broker-dealers, investment advisors and investment companies,
leasing, consumer finance, commercial finance, mortgage lending and insurance in
the foreign jurisdictions in which the Company Subsidiaries operate their
businesses, and the approval of such applications or the grant of required
licenses by such authorities, (iii) the filing of notification and report forms
with the United States Federal Trade Commission and the United States Department
of Justice under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as
amended (the "HSR Act") and the expiration or termination of any applicable
waiting period thereunder, (iv) the filing of applications and notices, as
applicable, with foreign governmental authorities under the Foreign Competition
Laws, and the approval of such applications by such authorities, if required,
(v) the filing with the SEC of a proxy statement in definitive form relating to
the meeting of Company's stockholders to be held in connection with this
Agreement and the transactions contemplated hereby and the filing and
declaration of effectiveness of the registration statement on Form F-4 relating
to the shares of Merger Partner Common Stock to be is-


                                       10
<PAGE>

sued in the Merger, (vi) the filing of the Certificate of Merger with the
Secretary of State of the State of Delaware pursuant to the DGCL, (vii) the
approval of the listing of the Merger Partner Common Stock to be issued in the
Merger on the New York Stock Exchange (the "NYSE"), (viii) such notices,
consents, approvals, filings or registrations appearing on the supplement to the
Company Disclosure Letter to be delivered by Company to Merger Partner as
promptly as reasonably practicable following the date hereof (the "Supplemental
Disclosure Letter"), and (ix) such other notices, consents, approvals, filings
or registrations, the failure of which to be made or obtained would not,
individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect on Company, no notices to, consents or approvals of, or filings
or registrations with, any court, administrative agency or commission or other
governmental authority or instrumentality (each, a "Governmental Entity") or
with any self-regulatory authority are necessary in connection with the
execution and delivery by Company of this Agreement and the consummation by
Company of the transactions contemplated hereby.

         3.6 SEC Reports; Company Financial Statements.

                  (a) Since January 1, 1997, Company has in all material
respects timely filed all reports, registration statements, proxy statements or
information statements and all other documents, together with any amendments
required to be made thereto, required to be filed with the Securities and
Exchange Commission ("SEC") under the Securities Act of 1933 (the "Securities
Act") or the Securities Exchange Act of 1934 (the "Exchange Act") (collectively,
the "Company Reports"). Company has heretofore made available to Merger Partner
true copies of all the Company Reports, together with all exhibits thereto, that
Merger Partner has requested.

                  (b) All of the financial statements included in the Company
Reports (which are collectively referred to herein as the "Company Consolidated
Financial Statements") fairly presented in all material respects the
consolidated financial position of Company and its subsidiaries as at the dates
mentioned and the consolidated results of operations, changes in stockholders'
equity and cash flows for the periods then ended in conformity with generally
accepted accounting principles applied on a consistent basis (subject to any
exceptions specified therein or as may be indicated in the notes thereto or in
the case of the unaudited statements, as may be permitted by Form 10-Q of the
SEC and subject, in the case of unaudited statements, to normal audit
adjustments). As at the respective dates of the consolidated balance sheets of
Company and its Subsidiaries included in such Company Reports, the Company
Reports complied in all material respects with all applicable rules and
regulations promulgated by the SEC and did not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. Except as set forth in the Company
Reports, as at the respective dates of the respective consolidated balance
sheets contained therein, neither Company nor any Company Subsidiary had any
liabilities or obligations of any nature (whether accrued, absolute, contingent
or otherwise) required by generally accepted accounting principles to be set
forth on a consolidated balance sheet of Company and its consolidated
subsidiaries or in the notes thereto, other than liabilities or obligations
which would not individually or in the aggregate reasonably be expected to have
a Material Adverse Effect on Company.

                                       11
<PAGE>

         3.7 Statutory Statements. Company has previously made available to
Merger Partner the annual statements of each Company Significant Subsidiary that
is engaged in the business of insurance (a "Company Insurance Subsidiary") for
the years ended December 31, 1996 and December 31, 1997, which have been filed
with the insurance regulatory authority of the jurisdiction of organization of
such Company Insurance Subsidiary, and statutory statements, where required, for
each such company for the periods ended March 31, 1998, June 30, 1998 and
September 30, 1998 and Company shall promptly furnish to Merger Partner all
statutory statements for any calendar years or quarters ending thereafter but
prior to the Effective Time. Such statutory statements present or will present
fairly in all material respects the financial position of each respective
Company Insurance Subsidiary at the end of each of the periods then ended, and
the results of its operations and changes in its surplus for each of the periods
then ended, in conformity with accounting practices prescribed or permitted by
the insurance regulatory authority of the jurisdiction of organization of such
Company Insurance Subsidiary, applied on a consistent basis as and to the extent
described in such statutory statements. For purposes of this Section 3.7,
materiality shall be determined by reference to Company and its Subsidiaries
taken as a whole.

         3.8 Absence of Certain Changes or Events. Since December 31, 1997 (with
respect to clauses (i), (ii), (iii), (v) and (vi)) and September 30, 1998 (with
respect to clause (iv)), there has not been (i) any change on a consolidated
basis in the business, financial condition or the annual earnings capacity of
Company and the Company Subsidiaries which constituted a Material Adverse Effect
on Company, (ii) any declaration, setting aside or payment of any dividend or
other distribution (whether in cash, stock or property) with respect to any of
Company's outstanding capital stock (other than the regular quarterly dividend
and the stock dividend referred to in clause (iii) hereof), (iii) any split
(other than the stock dividend declared December 17, 1998), combination or
reclassification of any of Company's outstanding capital stock or any issuance
or the authorization of any issuance of any other securities in respect of, in
lieu of or in substitution for shares of Company's outstanding capital stock,
(iv) (x) any granting by Company or any Company Subsidiary to any executive
officer of Company or any Company Subsidiary of any increase in compensation,
except for increases in the ordinary course of business consistent with prior
practice or as was required under employment agreements in effect as of
September 30, 1998, or in connection with a promotion, (y) any granting by
Company or any Company Subsidiary to any such executive officer of any increase
in severance or termination pay, except (A) for obligations which have been
satisfied prior to the date hereof, (B) for increases in the ordinary course of
business consistent with past practice in any one case not in excess of
$100,000, or (C) as was required under any employment, severance or termination
agreements in effect as of September 30, 1998, or (D) in connection with a
promotion, (z) any entry by Company or any Company Subsidiary into any new
severance or termination agreement with any such executive officer (other than
(A) for obligations which have been satisfied prior to the date hereof, (B) new
severance or termination obligations in the ordinary course of business in any
one case not in excess of $100,000, and (C) in connection with a promotion), (v)
any significant change in accounting methods, principles or practices by either
Company's life insurance business or non-life insurance business materially
affecting its assets, liabilities or business, except insofar as may be
appropriate to conform to changes in statutory accounting rules or generally
accepted accounting principles and except as would not have a Material Adverse
Effect on Company's life insurance 


                                       12
<PAGE>

business or non-life insurance business, as applicable or (vi) except for
changes in a manner consistent with past practice or consistent with industry
standards, any material change in the underwriting, pricing, actuarial or
investment practices or policies of either Company's life insurance business or
non-life insurance business, except as would not have a Material Adverse Effect
on the life insurance business or non-life insurance business, respectively.

         3.9 Taxes and Tax Returns.

                  (a) Company and the Company Subsidiaries have (i) duly filed
(or there has been filed on their behalf) with appropriate governmental
authorities all Tax Returns required to be filed by them, on or prior to the
date hereof, and all Tax Returns were in all material respects true, complete
and correct and filed on a timely basis (taking into account any extension of
time within which to file) except to the extent that any failure to file or
failure to be true, complete and correct would not, individually or in the
aggregate, have a Material Adverse Effect on Company, and (ii) duly paid in full
within the time and in the manner prescribed by law or made provisions in
accordance with generally accepted accounting principles with respect to Taxes
not yet due and payable (or there has been paid or provision has been made on
their behalf) for the payment of all Taxes for all periods ending on or prior to
the date hereof, except to the extent that any failure to fully pay or make
provision for the payment of such Taxes would not, individually or in the
aggregate, have a Material Adverse Effect on Company.

                  (b) No federal, state, local or foreign Tax audits,
investigations or other administrative proceedings or court proceedings are
presently pending or threatened in writing with regard to any Taxes or Tax
Returns of Company or the Company Subsidiaries, and no issues have been raised
in writing by any Tax authority and not fully settled in connection with any Tax
or Tax Return, in either case, which individually or in the aggregate would have
a Material Adverse Effect on Company.

                  (c) The federal income Tax Returns of Company and the Company
Subsidiaries have been examined by the Internal Revenue Service ("IRS") (or the
applicable statutes of limitation for the assessment of federal income Taxes for
such periods have expired) for all periods through and including December 31,
1995. Deficiencies for all periods 1995 and prior have been assessed by the IRS
and have either been paid or are being contested in good faith. Unpaid Taxes
related to those issues being contested are provided for in the financial
statements and to the extent that such Taxes are not provided for, the ultimate
payment would not individually or in the aggregate have a Material Adverse
Effect on Company.

                  (d) Neither Company nor any Company Subsidiary is party to any
agreement relating to the allocation or sharing of Taxes, other than agreements
among Company and the Company Subsidiaries. Neither Company nor any Company
Subsidiary (i) since January 1, 1994 has been a member of an affiliated group
filing a U.S. consolidated federal income tax return (other than a group the
common parent of which was Company) or an affiliated, consolidated, combined or
unitary group for state income tax return purposes (other than a group the
common parent of which was Company or a Company Subsidiary) or (ii) has any
liability for Taxes of any Person (other than Company and the Company
Subsidiaries) under United States Treasury 


                                       13
<PAGE>

Regulation Section 1.1502-6 (or any provision of state, local, or foreign law),
as a transferee or successor, by contract or otherwise. Except as set forth in
the Company Disclosure Letter, neither Company nor any Company Subsidiary is
currently under (i) any obligation to pay any amounts as a result of being
party, or having been party, to any Tax sharing agreement, other than agreements
among Company and the Company Subsidiaries or (ii) any express or implied
obligation to indemnify any other person for Taxes.

                  (e) There are no Tax liens upon any asset of Company or any
Company Subsidiary except liens for Taxes not yet due or Taxes that are being
contested in good faith by appropriate proceedings.

                  (f) (i) All insurance or investment policies, plans, or
contracts, financial products, employee benefit plans, individual retirement
accounts, or any similar or related policy, contract, plan or product, whether
individual, group or otherwise including annuity contracts, life insurance
contracts and variable contracts (including any supplements, endorsements,
riders and ancillary agreements in connection therewith), (the "Insurance
Product(s)") issued, assumed, modified, exchanged or sold by a Company Insurance
Subsidiary complies (and has complied since the time of issuance, assumption,
modification, exchange or sale) with all requirements of the Code, and the rules
and regulations thereunder, relating to the qualifications and/or tax treatment
for which the Insurance Products were intended to qualify or for which a Company
Insurance Subsidiary represented any or all of the Insurance Products qualified,
except for failures to comply or qualify that would not, individually, or in the
aggregate, have a Material Adverse Effect on Company.

                  (ii) In providing recordkeeping and administrative services in
the ordinary course with respect to customers' Insurance Products whether
individual or group retirement or deferred compensation plans or arrangements,
and with respect to any life insurance or annuity contracts issued, assumed,
modified, exchanged or sold by a Company Insurance Subsidiary as of the Closing
Date, each Company Insurance Subsidiary is in compliance with the applicable
administrative requirements of the Code and the rules and regulations
thereunder, and, to the extent applicable, the requirements of Parts 2, 3 and 4
of Title I of ERISA , except for failures to comply that would not individually,
or in the aggregate, have a Material Adverse Effect on Company.

         3.10 Litigation. Neither Company nor any Company Subsidiary is a party
to any pending or, to the knowledge of Company, threatened claim, action, suit,
investigation or proceeding which would reasonably be expected to have, either
individually or in the aggregate, a Material Adverse Effect on Company. There is
no outstanding order, writ, judgment, stipulation, injunction, decree,
determination, award or other decision against Company or any Company Subsidiary
which, either individually or in the aggregate, has had or would have a Material
Adverse Effect on Company.

         3.11 Contracts and Commitments. To the knowledge of Company, neither
Company nor any Company Subsidiary has received notice from any person alleging
that Company or any Company Subsidiary is in default under any contracts,
agreements, leases, commitments, or as-


                                       14
<PAGE>

signments in other interests which are material to Company and the Company
Subsidiaries as a whole which would result, individually or in the aggregate, in
a Material Adverse Effect on Company.

         3.12 Registration Statement, Etc. None of the information supplied or
to be supplied by Company for inclusion or incorporation by reference in (a) the
Registration Statement to be filed by Merger Partner with the SEC in connection
with the Merger Partner Common Stock to be issued in the Merger (the
"Registration Statement"), (b) the Proxy Statement (the "Proxy Statement") to be
mailed to Company's stockholders in connection with the meeting (the
"Stockholders' Meeting") to be called to consider the Merger, and (c) any other
documents to be filed with the SEC in connection with the transactions
contemplated hereby will, at the respective times such documents are filed and
at the time such documents become effective or at the time any amendment or
supplement thereto becomes effective contain any untrue statement of a material
fact, or omit to state any material fact required or necessary in order to make
the statements therein not misleading; and, in the case of the Registration
Statement, when it becomes effective or at the time any amendment or supplement
thereto becomes effective, will cause the Registration Statement or such
supplement or amendment to contain any untrue statement of a material fact, or
omit to state any material fact required to be stated therein or which is
necessary in order to make the statements therein not misleading; or, in the
case of the Proxy Statement, when first mailed to the stockholders of Company,
or in the case of the Proxy Statement or any amendment thereof or supplement
thereto, at the time of the Stockholders' Meeting, will cause the Proxy
Statement or any amendment thereof or supplement thereto to contain any untrue
statement of a material fact, or omit to state any material fact required to be
stated therein or necessary in order to make the statements therein, in light of
the circumstances under which they were made, not misleading. All documents that
Company is responsible for filing with the SEC and any other regulatory agency
in connection with the Merger will comply as to form in all material respects
with the provisions of applicable law and any applicable rules or regulations
thereunder, except that no representation is made by Company with respect to
statements made therein based on information supplied by Merger Partner or with
respect to information concerning Merger Partner or Sub which is incorporated by
reference in the Registration Statement or the Proxy Statement.

         3.13 Employee Benefit Plans.

                  (a) Schedule 3.13 of the Supplemental Company Disclosure
Letter shall contain a list of each material plan, program or contract which is
maintained by Company or any Company Subsidiary or to which Company or any
Company Subsidiary is obligated to make contributions and which provides
benefits or compensation to or on behalf of persons employed or formerly
employed in the United States, including but not limited to material executive
arrangements (for example, any bonus, incentive compensation, stock option,
deferred compensation, commission, severance, golden parachute or other
executive compensation plans, programs, contracts or arrangements) and "employee
benefit plans" as defined in Section 3(1) of the Employee Retirement Income
Security Act of 1974, as amended ("ERISA"). All such plans, programs,
arrangements, practices or contracts are referred to herein as "Company Employee
Plans." Company shall make available to Merger Partner the plan documents or
other writing constituting each Company Employee Plan and, if applicable, the
trust, insurance contract or other fund-


                                       15
<PAGE>

ing arrangement, the ERISA summary plan description and the most recent Forms
5500 and annual reports for each such plan. Schedule 3.13 of the Supplemental
Company Disclosure Letter shall identify those Company Employee Plans which
Company intends to satisfy the requirements of Section 401 of the Code and
Company shall make available to Merger Partner accurate copies of the most
recent favorable determination letters for such plans. For purposes of this
Agreement, the term "Company Foreign Plan" shall refer to each material plan,
program or contract that is subject to or governed by the laws of any
jurisdiction other than the United States, and which would have been treated as
a Company Employee Plan had it been a United States plan, program or contract.
Company shall use its reasonable best efforts to make available to Merger
Partner within thirty (30) days following the date of this Agreement a list and
copies of the Company Foreign Plans.

                  (b) With respect to each Company Employee Plan that is subject
to Title IV or Section 302 of ERISA or Section 412 or 4971 of the Code, except
as would not have a Material Adverse Effect on Company: (i) there does not exist
any accumulated funding deficiency within the meaning of Section 412 of the Code
or Section 302 of ERISA, whether or not waived; (ii) no reportable event within
the meaning of Section 4043(c) of ERISA with respect to which the 30-day notice
period has not been waived has occurred before the date of this Agreement, nor
will any such event occur solely as a result of the consummation of the
transactions contemplated by this Agreement; and (iii) all premiums required to
be paid to the Pension Benefit Guaranty Corporation have been timely paid in
full. Except as would not have a Material Adverse Effect on Company, there does
not now exist, nor do any circumstances exist that could result in, any Company
Controlled Group Liability (as defined below) that would be a liability of
Company or any Company Subsidiary following the Effective Time. "Company
Controlled Group Liability" means any and all liabilities under (i) Title IV of
ERISA, (ii) Section 302 of ERISA, (iii) Sections 412 and 4971 of the Code and
(iv) the continuation coverage requirements of Section 601 et seq. of ERISA and
Section 4980B of the Code, other than such liabilities that arise solely out of,
or relate solely to, the Company Employee Plans.

                  (c) Neither Company nor any Company Subsidiary is a
participant in a multi-employer plan (within the meaning of ERISA Section
3(37)). Except as disclosed in the Supplemental Company Disclosure Schedule,
neither Company nor any Company Subsidiary maintains a Company Employee Plan
which is subject to Title IV of ERISA and neither Company nor any Company
Subsidiary is obligated to provide post employment or retirement medical
benefits or any other unfunded welfare benefits to or on behalf of any person
who is no longer an employee of Company or any Company Subsidiary, except for
health continuation coverage as required by Section 4980B of the Code or Part 6
of Title I of ERISA.

                  (d) Each Company Employee Plan has at all times been
maintained, by its terms and in operation, in accordance with all applicable
laws, and each of those Company Employee Plans which are intended to be
qualified under Section 401 of the Code has at all times been maintained, by its
terms and in operation, in accordance with Section 401 of the Code, in each case
except where a failure to be so maintained would not have a Material Adverse
Effect on Company. As of December 31, 1997, neither Company nor any of the
Company Subsidiaries had any liability under any Company Employee Plan that was
not reflected in the Company 


                                       16
<PAGE>

audited consolidated balance sheet at December 31, 1997 or disclosed in the
notes thereto, other than liabilities which individually or in the aggregate
would not have a Material Adverse Effect on Company.

                  (e) No prohibited transaction has occurred with respect to any
Company Employee Plan maintained by Company or any of the Company Subsidiaries
that would result, directly or indirectly, in the imposition of an excise tax or
other liability under the Code or ERISA, except for such a tax or other
liability that would not have a Material Adverse Effect on Company.

                  (f) Except as previously disclosed to Merger Partner, the
execution of or performance of the transactions contemplated by this Agreement
will not create, accelerate or increase any obligations under the Company
Employee Plans which would have a Material Adverse Effect on Company.

                  (g) Except as would not have a Material Adverse Effect on
Company, with respect to each Company Foreign Plan: (i) all amounts required to
be reserved on account of each Company Foreign Plan have been so reserved in
accordance with reasonable accounting practices prevailing in the country where
such Company Foreign Plan is established; (ii) each Company Foreign Plan
required to be registered with a governmental entity has been registered, has
been maintained in good standing with the appropriate governmental entities, and
has been maintained and operated in accordance with its terms and applicable
law; and (iii) the fair market value of the assets of each funded Company
Foreign Plan that is a defined benefit pension plan (or termination indemnity
plan), and the liability of each insurer for each Company Foreign Plan that is a
defined benefit pension plan (or termination indemnity plan) and is funded
through insurance or the book reserve established for each Company Foreign Plan
that is a defined benefit pension plan (or termination indemnity plan) that
utilizes book reserves, together with any accrued contributions, is sufficient
to procure or provide for the liability for accrued benefits with respect to
those current and former employees of Company and any Company Subsidiary that
participates in such Company Foreign Plan according to the reasonable actuarial
or other applicable assumptions and valuations most recently used to determine
employer contributions to or the funded status or book reserve of such Company
Foreign Plans.

         3.14 Labor Matters. Neither Company nor any of its Subsidiaries has any
collective bargaining agreement with respect to its U.S. employees. Neither
Company nor any of its Subsidiaries is subject to a dispute, strike or work
stoppage with respect to any collective bargaining agreement, contract or other
agreement or understanding with a labor union or labor organization to which it
is a party or by which it is bound which would have a Material Adverse Effect on
Company. To Company's knowledge, there are no organizational efforts with
respect to the formation of a collective bargaining unit presently being made or
threatened involving employees of Company or any of its Subsidiaries, except for
those the formation of which would not have a Material Adverse Effect on
Company.

         3.15 Brokers and Finders. Neither Company nor any of the Company
Subsidiaries, nor any of their respective officers, directors or employees, has
employed any broker or finder or in-

                                       17
<PAGE>

curred any liability for any financial advisory fees, brokerage fees,
commissions, or finder's fees, and no broker or finder has acted directly or
indirectly for Company or any of the Company Subsidiaries, in connection with
this Agreement or any of the transactions contemplated hereby, except that
Company has retained Goldman, Sachs & Co. ("Goldman Sachs") as its financial
advisor, whose fees and expenses will be paid by Company.

         3.16 No Violation of Law.

                  (a) The business and operations of the Company Insurance
Subsidiaries have been conducted in compliance with all applicable statutes and
regulations regulating the business of insurance and all applicable orders and
directives of insurance regulatory authorities and market conduct
recommendations resulting from market conduct examinations of insurance
regulatory authorities (collectively, "Insurance Laws"), except where the
failure to so conduct such business and operations would not individually or in
the aggregate have a Material Adverse Effect on Company. Notwithstanding the
generality of the foregoing, except where the failure to do so would not have,
individually or in the aggregate, a Material Adverse Effect on Company, each
Company Insurance Subsidiary has marketed, sold and issued insurance products in
compliance, in all material respects, with all statutes, laws, ordinances,
rules, orders and regulations applicable to the business of such Company
Insurance Subsidiary and in the respective jurisdictions in which such products
have been sold, including, without limitation, in compliance with (i) all
applicable requirements relating to the disclosure of the nature of insurance
products as policies of insurance and (ii) all applicable requirements relating
to insurance product projections. In addition (i) there is no pending or, to the
knowledge of Company, threatened, charge by any insurance regulatory authority
that any of the Company Insurance Subsidiaries has violated, nor any pending or,
to the knowledge of Company, threatened, investigation by any insurance
regulatory authority with respect to possible violations of, any applicable
Insurance Laws where such violations would have individually or in the aggregate
a Material Adverse Effect on Company; (ii) none of the Company Insurance
Subsidiaries is subject to any order or decree of any insurance regulatory
authority relating specifically to such Company Insurance Subsidiary (as opposed
to insurance companies generally) which would have individually or in the
aggregate a Material Adverse Effect on Company; and (iii) the Company Insurance
Subsidiaries have filed all reports required to be filed with any insurance
regulatory authority on or before the date hereof as to which the failure to
file such reports would have individually or in the aggregate a Material Adverse
Effect on Company.

                  (b) In addition to Insurance Laws, the business and operations
of Company and the Company Subsidiaries have been conducted in compliance with
all other applicable laws, ordinances, regulations and orders of all
governmental entities and other regulatory bodies (including, without
limitation, laws, ordinances, regulations and orders relating to commercial
lending, commercial leasing, real estate servicing, and the safety and health of
employees), except where such noncompliance, individually or in the aggregate,
would not have a Material Adverse Effect on Company. In addition, (i) neither
Company nor any Company Subsidiary has been charged with or, to the knowledge of
Company, is now under investigation with respect to, a violation of any
applicable law, regulation, ordinance, order or other requirement of a
governmental entity or other regulatory body, which would have, individually or
in the aggregate, a Material Adverse 


                                       18
<PAGE>

Effect on Company, (ii) neither Company nor any Company Subsidiary is a party to
or bound by any order, judgment, decree or award of a governmental entity or
other regulatory body relating specifically to such entity which will have,
individually or in the aggregate, a Material Adverse Effect on Company; and
(iii) Company and the Company Subsidiaries have filed all reports required to be
filed with any governmental entity or other regulatory body (including self
regulatory organizations) on or before the date hereof as to which the failure
to file such reports would result, individually or in the aggregate, in a
Material Adverse Effect on Company. Company and the Company Subsidiaries have
all permits, certificates, licenses, approvals and other authorizations required
in connection with the operation of the business of Company and the Company
Subsidiaries, except for permits, certificates, licenses, approvals and other
authorizations the failure of which to have would not, individually or in the
aggregate, have a Material Adverse Effect on Company and except for such
permits, certificates, licenses, approvals and other authorizations required to
be obtained in connection with the consummation of the transactions contemplated
hereby.

         3.17 Environmental Matters. Except as would not have a Material Adverse
Effect on Company:

                  (a) there are not any past or present conditions or
circumstances that interfere with the conduct of the business of Company and
each of the Company Subsidiaries in the manner now conducted or which interfere
with compliance with any order of any court, governmental authority or
arbitration board or tribunal, or any law, ordinance, governmental rule or
regulation related to human health or the environment ("Environmental Law");

                  (b) there are not any past or present conditions or
circumstances at, or arising out of, any current or former business, assets or
properties of Company or any Company Subsidiary, including but not limited to
on-site or off-site disposal or release of any chemical substance, product or
waste, which could reasonably be expected to give rise to: (i) liabilities or
obligations for any cleanup, remediation, disposal or corrective action under
any Environmental Law or (ii) claims arising for personal injury, property
damage, or damage to natural resources; and

                  (c) neither Company nor any Company Subsidiary has (i)
received any written notice of noncompliance with, violation of, or liability or
potential liability under any Environmental Law or (ii) entered into any consent
decree or order or is subject to any order of any court or governmental
authority or tribunal under any Environmental Law or relating to the cleanup of
any hazardous materials contamination.

         3.18 Fairness Opinion. The Board of Directors of Company has received
an opinion dated as of the date hereof from Goldman Sachs to the effect that as
of such date the consideration to be received by the stockholders of Company
pursuant to the Merger is fair to such stockholders from a financial point of
view.

         3.19 Certain Approvals. Prior to the date hereof Company has taken all
appropriate actions so that the provisions of DGCL Section 203 will not apply
with respect to or as a result of this Agreement or the Merger.

                                       19
<PAGE>

         3.20 Merger. Neither Company nor any Company Subsidiary has taken any
action or failed to take any action which action or failure to take action would
cause the Merger not to qualify as a reorganization within the meaning of
Section 368(a) of the Code.

         3.21 Voting Requirements. The affirmative vote of the holders of a
majority of the shares of Company Common Stock with respect to this Agreement
and the Merger is the only vote of the holders of any class or series of
Company's capital stock necessary to approve this Agreement and the transactions
contemplated by this Agreement.

         3.22 Computer Software/Year 2000.

                  (a) Company or Company Subsidiaries own, or possess adequate
rights to use, all computer software programs that are material to the conduct
of the business of Company and the Company Subsidiaries taken as a whole, except
as would not have a Material Adverse Effect on Company. There are no
infringement suits, actions or proceedings pending or, to the knowledge of
Company, threatened against Company or any Company Subsidiary with respect to
any software owned or licensed by Company or any Company Subsidiary, which would
have, either individually or in the aggregate, a Material Adverse Effect on
Company.

                  (b) Company has and is implementing a Year 2000 remediation
plan (the "Company Y2K Plan") which contains inventory, assessment, remediation,
testing and implementation phases, and contingency plans, and Merger Partner has
been provided with information regarding such plan and access to employees of
Company responsible for such plan.

         3.23 Intellectual Property. Company owns, or possesses adequate rights
to use, all Intellectual Property that is used in the conduct of the business of
Company and the Company Subsidiaries taken as a whole, except as would not have
a Material Adverse Effect on Company. To the knowledge of Company, Company has
not received any notice of any conflict with or violation or infringement of,
any asserted rights of any other person with respect to any Intellectual
Property owned or licensed by Company or any Company Subsidiary, which would
have, either individually or in the aggregate, a Material Adverse Effect on
Company. The conduct of Company's and the Company Subsidiaries' respective
businesses as currently conducted does not conflict with any patents, patent
rights, licenses, trademarks, trademark rights, trade names, trade name rights
or copyrights of others, or any other rights with respect to Intellectual
Property, in any way likely to have, individually or in the aggregate, a
Material Adverse Effect on Company. There is no material infringement of any
proprietary right owned by or licensed by or to Company or any Company
Subsidiary which is likely to have, individually or in the aggregate, a Material
Adverse Effect on Company. As used in this Agreement, the phrase "Intellectual
Property" means all domestic or foreign patents, patent applications, inventions
(whether or not patentable), processes, products, technologies, discoveries,
copyrightable and copyrighted works, apparatus, trade secrets, trademarks
(registered and unregistered) and trademark applications and registrations,
brand names, certification marks, service marks and service mark applications
and registrations, trade names, trade dress, copyright registrations, design
rights, mask works, technical information (whether confidential or otherwise),
and all documentation thereof.


                                       20
<PAGE>

         3.24 Separate Accounts. Except as otherwise would not, individually or
in the aggregate, have a Material Adverse Effect on Company, each separate
account maintained by a Company Insurance Subsidiary (collectively, the "Company
Separate Accounts") is duly and validly established and maintained under the
laws of its state of formation and is either excluded from the definition of an
investment company pursuant to Section 3(c) (11) of the Investment Company Act
of 1940 (the "1940 Act") or is duly registered as an investment company under
the 1940 Act. Except as otherwise would not, individually or in the aggregate,
have a Material Adverse Effect on Company, each such Company Separate Account,
if registered, is operated in compliance with the 1940 Act, has filed all
reports and amendments of its registration statement required to be filed, and
has been granted all exemptive relief necessary for its operations as presently
conducted. Except as otherwise would not, individually or in the aggregate, have
a Material Adverse Effect on Company, the Company Insurance Contracts under
which Company Separate Account assets are held are duly and validly issued and
are either exempt from registration under the Securities Act pursuant to Section
3(a)(2) of the Securities Act or were sold pursuant to an effective registration
statement under the Securities Act, and any such registration statement is
currently in effect to the extent necessary to allow the appropriate Company
Insurance Subsidiary to receive contributions under such policies.

         3.25 Funds.

                  (a) Except as otherwise would not have a Material Adverse
Effect on Company, (i) each mutual fund sponsored by Company or a Company
Subsidiary sponsored by a Company Subsidiary (the "Funds") is duly registered
with the SEC as an open-end management investment company under the 1940 Act or,
in the case of one bond fund, is so registered as a closed-end fund, (ii) each
Fund is in material compliance with the 1940 Act and the SEC regulations
promulgated thereunder, including the requirements to file semiannual or annual
reports on N-SAR with the SEC, (iii) all shares of the Funds are duly registered
under the Securities Act and any applicable state securities laws, and (iv) each
of the Funds is duly incorporated and in good standing under the laws of the
state of its incorporation or is a validly existing business trust under the
laws of the jurisdiction in which it was formed.

                  (b) Except as otherwise would not have a Material Adverse
Effect on Company, Transamerica Investment Services is duly registered under the
Investment Advisers Act of 1940.

         3.26 Insurance. Company and the Company Subsidiaries maintain insurance
coverage reasonably customary or adequate for the operation of their respective
businesses (taking into account the cost and availability of such insurance).

                                    ARTICLE 4

                        REPRESENTATIONS AND WARRANTIES OF
                             MERGER PARTNER AND SUB

         Except as set forth in the disclosure letter delivered to Company
concurrent with the execution hereof (the "Merger Partner Disclosure Letter") or
the Merger Partner Supplemental Disclosure Letter (as defined below) or as
disclosed in the Merger Partner Reports (as defined 


                                       21
<PAGE>

below) filed prior to the date hereof, each of Merger Partner and Sub hereby
represents and warrants to Company as follows:

         4.1 Organization, Good Standing and Power.

                  (a) Merger Partner and Sub are corporations duly organized,
validly existing and in good standing under the laws of their respective
jurisdictions of incorporation and each has all requisite corporate power and
authority to own, lease and operate its properties and to carry on its business
as now being conducted. Merger Partner is duly qualified or licensed to do
business and is in good standing in each jurisdiction in which the nature of its
business or the ownership or leasing of its properties make such qualification
or licensing necessary, except where the failure to be so qualified or licensed
or to be in good standing would not, individually or in the aggregate, have a
Material Adverse Effect on Merger Partner. Merger Partner has delivered to
Company complete and correct copies of its and Sub's articles or certificate of
incorporation, bylaws or other organizational documents and all amendments
thereto to the date hereof. As used in this Agreement, the phrase "Material
Adverse Effect on Merger Partner" means a material adverse effect on (a) on a
consolidated basis, the financial condition, business or the annual earnings
capacity of Merger Partner and the Subsidiaries of Merger Partner (the "Merger
Partner Subsidiaries"), except to the extent that such adverse effect results
from general economic conditions or changes therein, financial market
fluctuations, conditions or adverse changes in or affecting the insurance
industry generally, or as a consequence of the transactions contemplated herein
(including, without limitation, the announcement thereof) or (b) the ability of
Merger Partner or Sub to consummate the transactions contemplated by this
Agreement.

                  (b) Each Merger Partner Subsidiary is a corporation duly
organized, validly existing and in good standing (where such concept exists)
under the laws of its jurisdiction of incorporation, and has the corporate (or,
if not a corporation, other) power and authority necessary for it to own or
lease its properties and assets and to carry on its business as it is now being
conducted, except where the failure to be so organized, existing or in good
standing (where such concept exists) or to have such power and authority would
not, individually or in the aggregate, have a Material Adverse Effect on Merger
Partner. Each Merger Partner Subsidiary is duly qualified or licensed to do
business and is in good standing in each jurisdiction in which the nature of its
business or the ownership or leasing of its properties makes such qualification
or licensing necessary, except where the failure to be so qualified or licensed
or to be in good standing would not, individually or in the aggregate, have a
Material Adverse Effect on Merger Partner.

         4.2 Capitalization. The authorized capital stock of Merger Partner
consists of 1,300,000,000 shares of Common Stock, par value of fifty cents
(0.50) Dutch Guilder per share, of which as of January 31, 1999, 583,180,340
shares were issued and outstanding, 700,000,000 shares of Preferred Stock, par
value fifty cents (0.50) Dutch Guilder per share ("Merger Partner Preferred
Stock"), of which as of the date hereof 230,000,000 shares are issued and
outstanding. All outstanding shares of Merger Partner Common Stock are, and all
shares which may be issued prior to the Effective Date pursuant to any
outstanding stock options issued by Merger Partner will be, when issued, duly
authorized, validly issued, fully paid and nonassessable and not sub-


                                       22
<PAGE>

ject to preemptive rights. All of the shares of Merger Partner Common Stock to
be issued at the Effective Time in accordance with this Agreement will be, when
so issued, duly authorized, validly issued, fully paid and nonassessable and
free of preemptive rights. Except as set forth above, as of January 31, 1999,
there were no shares of capital stock or other equity securities of Merger
Partner outstanding, and, except as set forth in Schedule 4.2 of the Merger
Partner Disclosure Letter, as of January 31, 1999 there are no outstanding
options, warrants or rights to purchase or acquire from Merger Partner any
capital stock of Merger Partner, there are no existing registration covenants
with Merger Partner with respect to outstanding shares of Merger Partner Common
Stock, and there are no convertible securities or other contracts, commitments,
agreements, understandings, arrangements or restrictions by which Merger Partner
is bound to issue any additional shares of its capital stock or other
securities.

         4.3 Merger Partner Significant Subsidiaries. Except as would not have a
Material Adverse Effect on Merger Partner, and except as disclosed in Schedule
4.3 of the Merger Partner Disclosure Letter, Merger Partner owns, directly or
indirectly, the securities of each Merger Partner Significant Subsidiary held by
Merger Partner, free and clear of all liens, charges, pledges, security
interests or other encumbrances. All of the capital stock of each Merger Partner
Significant Subsidiary has been duly authorized, and is validly issued, fully
paid and nonassessable. Except as disclosed in Schedule 4.3 of the Merger
Partner Disclosure Letter, there are no outstanding options or rights to
subscribe to, or any contracts or commitments to issue or sell any shares of the
capital stock or any securities or obligations convertible into or exchangeable
for, or giving any person any right to acquire, any shares of the capital stock
of any Merger Partner Significant Subsidiary to which Merger Partner or any
Merger Partner Significant Subsidiary is a party. Except as disclosed in
Schedule 4.3 of the Merger Partner Disclosure Letter, there are no voting trusts
or other agreements or understandings with respect to the voting of capital
stock of Merger Partner or any Merger Partner Significant Subsidiary to which
Merger Partner or any Merger Partner Significant Subsidiary is a party. Schedule
4.3 to the Merger Partner Disclosure Letter sets forth for each Significant
Subsidiary of Merger Partner, its name and jurisdiction of incorporation or
organization.

         4.4 Authority; Enforceability. Each of Merger Partner and Sub has the
corporate power and authority to enter into this Agreement and to consummate the
transactions contemplated hereby. The execution and delivery of this Agreement
and the consummation of the transactions contemplated hereby do not require the
approval, authorization or consent of any work council, and have been duly
authorized by all necessary corporate action on the part of each of Merger
Partner and Sub other than the approval of the Issuance by Merger Partner's
stockholders (including all necessary approvals on the part of Vereniging AEGON
(the "Association")), and this Agreement has been duly executed and delivered by
Merger Partner and Sub and constitutes the valid and binding obligation of each
such party, enforceable against it in accordance with its terms, (i) except as
may be limited by bankruptcy, insolvency, moratorium or other similar laws
affecting or relating to enforcement of creditors' rights generally and (ii)
subject to general principles of equity.

                                       23
<PAGE>

         4.5 Non-Contravention; Consents.

                  (a) Except as would not have a Material Adverse Effect on
Merger Partner, neither the execution, delivery and performance by Merger
Partner or Sub of this Agreement, nor the consummation by Merger Partner or Sub
of the transactions contemplated hereby, nor compliance by Merger Partner or Sub
with any of the provisions hereof, will:

                  (i) violate, conflict with, result in a breach of any
         provision of, constitute a default (or an event that, with notice or
         lapse of time or both, would constitute a default) under, result in the
         termination of, accelerate the performance required by, or result in a
         right of termination or acceleration, or the creation of any lien,
         security interest, charge or encumbrance upon any of the properties or
         assets of Merger Partner or Sub, under any of the terms, conditions or
         provisions of, (x) its respective organizational documents, or (y) any
         note, bond, mortgage, indenture, deed of trust, license, lease,
         contract agreement or other instrument or obligation to which Merger
         Partner or any of the Merger Partner Subsidiaries is a party, or by
         which Merger Partner or any of the Merger Partner Subsidiaries may be
         bound, or to which Merger Partner or any of the Merger Partner
         Subsidiaries or the properties or assets of any of them may be subject;
         or

                  (ii) subject to compliance with the statutes and regulations
         referred to in Section 4.5, violate any valid and enforceable judgment,
         ruling, order, writ, injunction, decree, or any statute, rule or
         regulation applicable to Merger Partner or any of the Merger Partner
         Subsidiaries or any of their respective properties or assets.

                  (b) Except for (i) the filing of applications and notices, as
applicable, with federal and state regulatory authorities governing banking,
insurance premium finance, commercial collections, broker-dealers, investment
advisors and investment companies, leasing, consumer finance, commercial
finance, mortgage lending and insurance in the states in which Merger Partner
and the Merger Partner Subsidiaries operate their respective business and the
approval of such applications or the grant of required licenses by such
authorities, (ii) the filing of applications and notices, as applicable, with
the foreign governmental authorities regulating banking, insurance premium
finance, commercial collections, broker-dealers, investment advisors and
investment companies, leasing, consumer finance, commercial finance, mortgage
lending and insurance in the foreign jurisdictions in which the Merger Partner
Subsidiaries operate their businesses, and the approval of such applications or
the grant of required licenses by such authorities, (iii) the filing of
notification and report forms under the HSR Act and the expiration or
termination of any applicable waiting period thereunder, (iv) the filing of
applications and notices, as applicable, with foreign governmental authorities
under the Foreign Competition Laws, and the approval of such applications by
such authorities, if required, (v) the filing with the SEC of a proxy statement
in definitive form relating to the meetings of Company's stockholders to be held
in connection with this Agreement and the transactions contemplated hereby and
the filing and declaration of effectiveness of the registration statement on
Form F-4 relating to the shares of Merger Partner Common Stock to be issued in
the Merger, (vi) the filing of the Certificate of Merger with the Secretary of
State of the State of Delaware pursuant to the DGCL, and (vii) the 


                                       24
<PAGE>

approval of the listing of the Merger Partner Common Stock to be issued in the
Merger on the NYSE, no notices to, consents or approvals of, or filings or
registrations with, any Governmental Entity or with any self-regulatory
authority or with any third party are necessary in connection with the execution
and delivery by Merger Partner of this Agreement and the consummation by Merger
Partner of the transactions contemplated hereby, (viii) such notices, consents,
approvals, filings or registrations appearing on the supplement to the Merger
Partner Disclosure Letter to be delivered by Merger Partner to Company as
promptly as reasonably practicable following the date hereof (the "Merger
Partner Supplemental Disclosure Letter"), and (ix) such other notices, consents,
approvals, filings or registrations, the failure of which to be made or obtained
would not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect on Merger Partner, no notices to, consents or approvals
of, or filings or registrations with, any Governmental Entity or with any
self-regulatory authority are necessary in connection with the execution and
delivery by Merger Partner of this Agreement and the consummation by Merger
Partner of the transactions contemplated hereby.

         4.6 SEC Reports; Merger Partner Financial Statements.

                  (a) Since January 1, 1997, Merger Partner has timely filed all
reports, registration statements, proxy statements or information statements and
all other documents, together with any amendments required to be made thereto,
required to be filed with the SEC under the Securities Act or the Exchange Act
(collectively, the "Merger Partner Reports"). Merger Partner has heretofore made
available to Company true copies of all the Merger Partner Reports, together
with all exhibits thereto, that Company has requested.

                  (b) All of the financial statements included in the Merger
Partner Reports (which are collectively referred to herein as the "Merger
Partner Consolidated Financial Statements") fairly presented in all material
respects the consolidated financial position of Merger Partner and its
subsidiaries as at the dates mentioned and the consolidated results of
operations, changes in stockholders' equity and cash flows for the periods then
ended in conformity with Dutch generally accepted accounting principles with a
reconciliation on an annual basis to United States generally accepted accounting
principles applied on a consistent basis (subject to any exceptions specified
therein or as may be indicated in the notes thereto or in the case of the
unaudited statements, as may be permitted by Form 6-K of the SEC and subject, in
the case of unaudited statements, to normal, recurring audit adjustments). As at
the respective dates of the consolidated balance sheets of Merger Partner and
its Subsidiaries included in such Merger Partner Reports, the Merger Partner
Reports complied in all material respects with all applicable rules and
regulations promulgated by the SEC and did not contain any untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary in order to make the statements therein, in light of the circumstances
under which they were made, not misleading. Except as set forth in the Merger
Partner Reports, as at the respective dates of the respective consolidated
balance sheets contained therein, neither Merger Partner nor any Merger Partner
Subsidiary has any liabilities or obligations of any nature (whether accrued,
absolute, contingent or otherwise) required by Dutch generally accepted
accounting principles to be set forth on a consolidated balance sheet of Merger
Partner and its consolidated subsidiaries or in the 


                                       25
<PAGE>

notes thereto, other than liabilities or obligations which would not,
individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect on Merger Partner.

         4.7 Statutory Statements. Merger Partner has made available to Company
the annual statements (or equivalent statements) of each Merger Partner
Significant Subsidiary that is engaged in the business of insurance in the
United States, the United Kingdom and The Netherlands (a "Merger Partner
Insurance Subsidiary") for the years ended December 31, 1996 and December 31,
1997, which have been filed with the insurance regulatory authority of the
jurisdiction of organization of such Merger Partner Insurance Subsidiary, and
statutory statements, where required, for each such Merger Partner Insurance
Subsidiary for the periods ended March 31, 1998, June 30, 1998 and September 30,
1998, and Merger Partner shall promptly furnish to Company all statutory
statements for any calendar years or quarters ending thereafter but prior to the
Effective Time. Such statutory statements (or equivalent statements) present or
will present fairly in all material respects the financial position and surplus
of each Merger Partner Insurance Subsidiary at the end of each of the periods
then ended, and the results of its operations and changes in its surplus for
each of the periods then ended, in conformity with accounting practices
prescribed or permitted by the insurance regulatory authority of the
jurisdiction of organization of such Merger Partner Insurance Subsidiary,
applied on a consistent basis as and to the extent described in such statutory
statements (or equivalent statements). For the purposes of this Section 4.7,
materiality shall be determined by reference to Merger Partner and its
Subsidiaries taken as a whole.

         4.8 Absence of Certain Changes or Events. Since December 31, 1997,
Merger Partner and the Merger Partner Subsidiaries have conducted their business
in all material respects only in the ordinary course, and there has not been (i)
any change on a consolidated basis in the business, financial condition or the
annual earnings capacity of Merger Partner and the Merger Partner Subsidiaries
which constituted a Material Adverse Effect on Merger Partner, (ii) any
declaration, setting aside or payment of any dividend or other distribution
(other than regular dividends consistent with past practice) (whether in cash,
stock or property) with respect to any of Merger Partner's outstanding capital
stock, (iii) any split, combination or reclassification of any of Merger
Partner's outstanding capital stock or any issuance or the authorization of any
issuance of any other securities in respect of, in lieu of or in substitution
for shares of Merger Partner's outstanding capital stock, (iv) any significant
change in accounting methods, principles or practices by Merger Partner or any
Merger Partner Subsidiary materially affecting its assets, liabilities or
business, except insofar as may be appropriate to conform to changes in
statutory accounting rules or generally accepted accounting principles, or (v)
except for changes in a manner consistent with past practice or consistent with
industry standards, any material change in the underwriting, pricing, actuarial
or investment practices or policies of Merger Partner and its Subsidiaries taken
as a whole.

         4.9 Taxes and Tax Returns.

                  (a) Merger Partner and the Merger Partner Subsidiaries have
(i) duly filed (or there has been filed on their behalf) with appropriate
governmental authorities all Tax Returns required to be filed by them, on or
prior to the date hereof, and all Tax Returns were in all mate-


                                       26
<PAGE>

rial respects true, complete and correct and filed on a timely basis (taking
into account any extension of time within which to file) except to the extent
that any failure to file would not, individually or in the aggregate, have a
Material Adverse Effect on Merger Partner, and (ii) duly paid in full within the
time and in the manner prescribed by law or made provisions in accordance with
generally accepted accounting principles with respect to Taxes not yet due and
payable (or there has been paid or provision has been made on their behalf) for
the payment of all Taxes for all periods ending on or prior to the date hereof,
except to the extent that any failure to fully pay or make provision for the
payment of such Taxes would not, individually or in the aggregate, have a
Material Adverse Effect on Merger Partner.

                  (b) No federal, state, local or foreign audits, investigations
or other administrative proceedings or court proceedings are presently pending
or threatened in writing with regard to any Taxes or Tax Returns of Merger
Partner or the Merger Partner Subsidiaries and no issues have been raised in
writing by any Tax authority and not fully settled in connection with any Tax or
Tax Return wherein an adverse determination or ruling in any one such proceeding
or in all such proceedings in the aggregate would have a Material Adverse Effect
on Merger Partner.

         4.10 Litigation. Neither Merger Partner nor any Merger Partner
Subsidiary is a party to any pending or, to the knowledge of Merger Partner,
threatened, claim, action, suit, investigation or proceeding which would
reasonably be expected to have, either individually or in the aggregate, a
Material Adverse Effect on Merger Partner. There is no outstanding order, writ,
judgment, stipulation, injunction, decree, determination, award or other
decision against Merger Partner or any Merger Partner Subsidiary which, either
individually or in the aggregate, has had or would have a Material Adverse
Effect on Merger Partner.

         4.11 Contracts and Commitments. To the knowledge of Merger Partner
neither Merger Partner nor any Merger Partner Subsidiary has received notice
from any person alleging that Merger Partner or any Merger Partner Subsidiary is
in default under any contracts, agreements, leases, commitments, or assignments
in other interests which are material to Merger Partner and the Merger Partner
Subsidiaries as a whole as to which it is reasonably foreseeable that an adverse
determination would result, individually or in the aggregate, in a Material
Adverse Effect on Merger Partner.

         4.12 Registration Statement, Etc. None of the information supplied or
to be supplied by Merger Partner for inclusion or incorporation by reference in
(a) the Registration Statement, (b) the Proxy Statement and (c) any other
documents to be filed with the SEC in connection with the transactions
contemplated hereby will, at the respective times such documents are filed and
at the time such documents become effective or at the time any amendment or
supplement thereto becomes effective contain any untrue statement of a material
fact, or omit to state any material fact required or necessary in order to make
the statements therein not misleading; and, in the case of the Registration
Statement, when it becomes or at the time any amendment or supplement thereto
becomes effective, will cause the Registration Statement or such supplement or
amendment to contain any untrue statement of a material fact, or omit to state
any material fact required to be stated therein or which is necessary in order
to make the statements therein not misleading, or, in the case of the Proxy
Statement, when first mailed to the stockholders of Company, or in the case 


                                       27
<PAGE>

of the Proxy Statement or any amendment thereof or supplement thereto, at the
time of the Stockholders' Meeting, will cause the Proxy Statement or any
amendment thereof or supplement thereto to contain any untrue statement of a
material fact, or omit to state any material fact required to be stated therein
or necessary in order to make the statements therein, in light of the
circumstances under which they were made, not misleading. All documents that
Merger Partner is responsible for filing with the SEC and any other regulatory
agency in connection with the Merger will comply as to form in all material
respects with the provisions of applicable law and any applicable rules or
regulations thereunder, except that no representation is made by Merger Partner
with respect to statements made therein based on information supplied by Company
or with respect to information concerning Company or Sub which is incorporated
by reference in the Registration Statement or the Proxy Statement.

         4.13 Employee Benefit Plans.

                  (a) Schedule 4.13 of the Merger Partner Supplemental
Disclosure Letter contains a list of each material plan, program, arrangement,
practice or contract which is maintained by Merger Partner or any Merger Partner
Subsidiary or to which Merger Partner or any Merger Partner Subsidiary is
obligated to make contributions and which provides benefits or compensation to
or on behalf of persons employed or formerly employed in the United States,
including but not limited to executive arrangements (for example, any bonus,
incentive compensation, stock option, deferred compensation, commission,
severance, golden parachute or other executive compensation plans, programs,
contracts or agreements) and "employee benefit plans" as defined in Section 3(1)
of ERISA. All such plans, programs, arrangements, practices or contracts are
referred to herein as "Merger Partner Employee Plans." Merger Partner has made
available to Company the plan documents or other writing constituting each
Merger Partner Employee Plan and, if applicable, the trust, insurance contract
or other funding arrangement, the ERISA summary plan description and the most
recent Forms 5500 and annual reports for each such plan. Merger Partner has
identified those Merger Partner Employee Plans which Merger Partner intends to
satisfy the requirements of Section 401 of the Code and has made available to
Company accurate copies of the most recent favorable determination letters for
such plans. For purposes of this Agreement, the term "Foreign Plan" shall refer
to each material plan, program or contract that is subject to or governed by the
laws of any jurisdiction other than the United States, and which would have been
treated as a Merger Partner Employee Plan had it been a United States plan,
program or contract. Merger Partner shall use its reasonable best efforts to
make available, promptly upon request to Company a list and/or copies of the
Foreign Plans.

                  (b) With respect to each Merger Partner Employee Plan that is
subject to Title IV or Section 302 of ERISA or Section 412 or 4971 of the Code:
(i) there does not exist any accumulated funding deficiency within the meaning
of Section 412 of the Code or Section 302 of ERISA, whether or not waived; (ii)
no reportable event within the meaning of Section 4043(c) of ERISA with respect
to which the 30-day notice period has not been waived has occurred, nor will any
such event occur solely as a result of the consummation of the transactions
contemplated by this Agreement and (iii) all premiums required to be paid to the
Pension Benefit Guaranty Corporation have been timely paid in full. There does
not now exist, nor do any circumstances exist that could result in, any Merger
Partner Controlled Group Liability (as defined below) that 


                                       28
<PAGE>

would be a liability of Merger Partner or any Merger Partner Subsidiary
following the Effective Time. "Merger Partner Controlled Group Liability" means
any and all liabilities under (i) Title IV of ERISA, (ii) Section 302 of ERISA,
(iii) Sections 412 and 4971 of the Code and (iv) the continuation coverage
requirements of Section 601 et seq. of ERISA and Section 4980B of the Code,
other than such liabilities that arise solely out of, or relate to, the Merger
Partner Employee Plans.

                  (c) Neither Merger Partner nor any Merger Partner Subsidiary
is, or has been, a participant in a multi-employer plan (within the meaning of
ERISA Section 3(37)). Neither Merger Partner nor any Merger Partner Subsidiary
maintains or has at any time maintained a Merger Partner Employee Plan which is
subject to Title IV of ERISA. Neither Merger Partner nor any Merger Partner
Subsidiary is obligated to provide post employment or retirement medical
benefits or any other unfunded welfare benefits to or on behalf of any person
who is no longer an employee of Merger Partner or any Merger Partner Subsidiary,
except for health continuation coverage as required by Section 4980B of the Code
or Part 6 of Title I of ERISA.

                  (d) Each Merger Partner Employee Plan has at all times been
maintained, by its terms and in operation, in accordance with all applicable
laws, and each of those Merger Partner Employee Plans which are intended to be
qualified under Section 401 of the Code has at all times been maintained, by its
terms and in operation, in accordance with Section 401 of the Code, except where
a failure to be so maintained would not have a Material Adverse Effect on Merger
Partner. As of December 31, 1997, neither Merger Partner nor any of the Merger
Partner Subsidiaries had any liability under any Merger Partner Employee Plan
that was not reflected in the Merger Partner audited consolidated balance sheet
at December 31, 1997 or disclosed in the notes thereto, other than liabilities
which individually or in the aggregate would not have a Material Adverse Effect
on Merger Partner.

                  (e) No prohibited transaction has occurred with respect to any
Merger Partner Employee Plan maintained by Merger Partner or any of the Merger
Partner Subsidiaries that would result, directly or indirectly, in the
imposition of an excise tax or other liability under the Code or ERISA, except
for such a tax or other liability that would not have a Material Adverse Effect
on Merger Partner.

                  (f) All contributions or premium payments with respect to the
Merger Partner Employee Plans due for any period ending on or before the
Effective Time have been or will be timely paid by Merger Partner. The execution
of or performance of the transactions contemplated by this Agreement will not
create, accelerate or increase any obligations under the Merger Partner Employee
Plans which would have a Material Adverse Effect on Merger Partner.

                  (g) Except as would not have a Material Adverse Effect on
Merger Partner, with respect to each Foreign Plan: (i) all amounts required to
be reserved under each book reserved Foreign Plan have been so reserved in
accordance with reasonable accounting practices prevailing in the country where
such Foreign Plan is established; (ii) each Foreign Plan required to be
registered with a governmental entity has been registered, has been maintained
in good standing with the appropriate governmental entities, and has been
maintained and operated in 


                                       29
<PAGE>

accordance with its terms and applicable law; and (iii) the fair market value of
the assets of each funded Foreign Plan that is a defined benefit pension plan
(or termination indemnity plan), and the liability of each insurer for each
Foreign Plan that is a defined benefit pension plan (or termination indemnity
plan) and is funded through insurance or the book reserve established for each
Foreign Plan that is a defined benefit pension plan (or termination indemnity
plan) that utilizes book reserves, together with any accrued contributions, is
sufficient to procure or provide for the liability for accrued benefits with
respect to those current and former employees of Merger Partner and any Merger
Partner Subsidiary that participate in such Foreign Plan according to the
reasonable actuarial or other applicable assumptions and valuations most
recently used to determine employer contributions to or the funded status or
book reserve of such Foreign Plans.

         4.14 Labor Matters. Neither Merger Partner nor any of its Subsidiaries
has any collective bargaining agreement with respect to its U.S. employees.
Neither Merger Partner nor any of its Subsidiaries is subject to a dispute,
strike or work stoppage with respect to any collective bargaining agreement,
contract or other agreement or understanding with a labor union or labor
organization to which it is a party or by which it is bound which would have a
Material Adverse Effect on Merger Partner. To Merger Partner's knowledge, there
are no organizational efforts with respect to the formation of a collective
bargaining unit presently being made or threatened involving employees of Merger
Partner or any of its Subsidiaries, except for those the formation of which
would not have a Material Adverse Effect on Merger Partner.

         4.15 Brokers and Finders. Neither Merger Partner nor any of the Merger
Partner Subsidiaries, nor any of their respective officers, directors or
employees, has employed any broker or finder or incurred any liability for any
financial advisory fees, brokerage fees, commissions, or finder's fees, and no
broker or finder has acted directly or indirectly for Merger Partner or any of
the Merger Partner Subsidiaries, in connection with this Agreement or any of the
transactions contemplated hereby, except that Merger Partner has retained
Donaldson, Lufkin & Jenrette Securities Corporation as its financial advisor,
whose fees and expenses will be paid by Merger Partner.

         4.16 No Violation of Law.

                  (a) The business and operations of the Merger Partner
Insurance Subsidiaries have been conducted in compliance with all applicable
Insurance Laws, except where the failure to so conduct such business and
operations would not individually or in the aggregate have a Material Adverse
Effect on Merger Partner. Notwithstanding the generality of the foregoing,
except where the failure to do so would not have, individually or in the
aggregate, a Material Adverse Effect on Merger Partner and each Merger Partner
Insurance Subsidiary have marketed, sold and issued insurance products in
compliance, in all material respects, with all statutes, laws, ordinances,
rules, orders and regulations applicable to the business of such Merger Partner
Insurance Subsidiary and in the respective jurisdictions in which such products
have been sold, including, without limitation, in compliance with (i) all
applicable requirements relating to the disclosure of the nature of insurance
products as policies of insurance and (ii) all applicable requirements relating
to insurance product projections. In addition (i) there is no pending or, to the
knowledge of Merger Partner, threatened, charge by any insurance regulatory
authority that 


                                       30
<PAGE>

any of the Merger Partner Insurance Subsidiaries has violated, nor any pending
or, to the knowledge of Merger Partner, threatened, investigation by any
insurance regulatory authority with respect to possible violations of, any
applicable Insurance Laws where such violations would have individually or in
the aggregate a Material Adverse Effect on Merger Partner; (ii) none of the
Merger Partner Insurance Subsidiaries is subject to any order or decree of any
Merger Partner Insurance Subsidiary regulatory authority relating specifically
to such Merger Partner Insurance Subsidiary (as opposed to insurance companies
generally) which would have individually or in the aggregate a Material Adverse
Effect on Merger Partner; and (iii) the Merger Partner Insurance Subsidiaries
have filed all reports required to be filed with any insurance regulatory
authority on or before the date hereof as to which the failure to file such
reports would have individually or in the aggregate a Material Adverse Effect on
Merger Partner.

                  (b) In addition to Insurance Laws, the business and operations
of Merger Partner and the Merger Partner Subsidiaries have been conducted in
compliance with all other applicable laws, ordinances, regulations and orders of
all governmental entities and other regulatory bodies (including, without
limitation, laws, ordinances, regulations and orders relating to the safety and
health of employees), except where such noncompliance, individually or in the
aggregate, would not have a Material Adverse Effect on Merger Partner. In
addition, (i) neither Merger Partner nor any Merger Partner Subsidiary has been
charged with or, to the knowledge of Merger Partner, is now under investigation
with respect to, a violation of any applicable law, regulation, ordinance, order
or other requirement of a governmental entity or other regulatory body, which
violations or penalties would have, individually or in the aggregate, a Material
Adverse Effect on Merger Partner; (ii) neither Merger Partner nor any Merger
Partner Subsidiary is a party to or bound by any order, judgment, decree or
award of a governmental entity or other regulatory body relating specifically to
such entity which will have, individually or in the aggregate, a Material
Adverse Effect on Merger Partner; and (iii) Merger Partner and the Merger
Partner Subsidiaries have filed all reports required to be filed with any
governmental entity or other regulatory body (including self-regulatory
organizations) on or before the date hereof as to which the failure to file such
reports would result, individually or in the aggregate, in a Material Adverse
Effect on Merger Partner. Merger Partner and the Merger Partner Subsidiaries
have all permits, certificates, licenses, approvals and other authorizations
required in connection with the operation of the business of Merger Partner and
the Merger Partner Subsidiaries, except for permits, certificates, licenses,
approvals and other authorizations the failure of which to have would not have,
individually or in the aggregate, a Material Adverse Effect on Merger Partner
and except for such permits, certificates, licenses, approvals and other
authorizations required to be obtained in connection with the consummation of
the transactions contemplated hereby.

         4.17 Environmental Matters. Except as would not have a Material Adverse
Effect on Merger Partner:

                  (a) there are not any past or present conditions or
circumstances that interfere with the conduct of the business of Merger Partner
and each of the Merger Partner Subsidiaries in the manner now conducted or which
interfere with compliance with any order or any court, governmental authority or
arbitration board or tribunal, or any Environmental Law;


                                       31
<PAGE>

                  (b) there are not any past or present conditions or
circumstances at, or arising out of, any current or former business, assets or
properties of Merger Partner or any Merger Partner Subsidiary, including but not
limited to on-site or off-site disposal or release of any chemical substance,
product or waste, which could reasonably be expected to give rise to: (i)
liabilities or obligations for any cleanup, remediation, disposal or corrective
action under any Environmental Law or (ii) claims arising for personal injury,
property damage, or damage to natural resources; and

                  (c) neither Merger Partner nor any Merger Partner Subsidiary
has (i) received any written notice of noncompliance with, violation of, or
liability or potential liability under any Environmental Law or (ii) entered
into any consent decree or order or is subject to any order of any court or
governmental authority or tribunal under any Environmental Law or relating to
the cleanup of any hazardous materials contamination.

         4.18 Interim Operations of Sub. Sub was formed solely for the purpose
of engaging in the transactions contemplated hereby, has engaged in no other
business activities and has conducted its operations only as contemplated
hereby.

         4.19 Merger. Neither Merger Partner nor any Merger Partner Subsidiary
has taken any action or failed to take any action which action or failure to
take action would cause the Merger not to qualify as a reorganization within the
meaning of Section 368(a) of the Code.

         4.20 Computer Software/Year 2000.

                  (a) Merger Partner or Merger Partner Subsidiaries own, or
possess valid license rights to, all computer software programs that are
material to the conduct of the business of Merger Partner and the Merger Partner
Subsidiaries taken as a whole except as would not have a Material Adverse Effect
on Merger Partner. There are no infringement suits, actions or proceedings
pending or, to the knowledge of Merger Partner, threatened against Merger
Partner or any Merger Partner Subsidiary with respect to any software owned or
licensed by Merger Partner or any Merger Partner Subsidiary, which would have,
either individually or in the aggregate, a Material Adverse Effect on Merger
Partner.

                  (b) Merger Partner has and is implementing a Year 2000
remediation plan (the "Merger Partner Y2K Plan") which contains inventory,
assessment, remediation, testing and implementation phases, and contingency
plans, and Company has been provided with information regarding such plan and
access to employees of Merger Partner responsible for such plan.

         4.21 Intellectual Property. Merger Partner owns, or possesses adequate
rights to, all Intellectual Property that is used in the conduct of the business
of Merger Partner and the Merger Partner Subsidiaries taken as a whole except as
would not have a Material Adverse Effect on Merger Partner. To the knowledge of
Merger Partner, Merger Partner has not received any notice of any conflict with
or violation or infringement of, any asserted rights of any other person with
respect to any Intellectual Property owned or licensed by Merger Partner or any
Merger Partner Subsidiary, which would have, either individually or in the
aggregate, a Material Adverse Effect on Merger Partner. The conduct of Merger
Partner's and the Merger Partner Subsidiaries' 


                                       32
<PAGE>

respective businesses as currently conducted does not conflict with any patents,
patent rights, licenses, trademarks, trademark rights, trade names, trade name
rights or copyrights of others, or any other rights with respect to Intellectual
Property, in any way likely to have, individually or in the aggregate, a
Material Adverse Effect on Merger Partner. There is no material infringement of
any proprietary right owned by or licensed by or to Merger Partner or any Merger
Partner Subsidiary which is likely to have, individually or in the aggregate, a
Material Adverse Effect on Merger Partner.

         4.22 Insurance. Merger Partner and the Merger Partner Subsidiaries
maintain insurance coverage reasonably customary or adequate for the operation
of their respective businesses (taking into account the cost and availability of
such insurance).

         4.23 Affiliate Transactions. Except as set forth in Section 4.23 of the
Merger Partner Disclosure Letter, none of Merger Partner nor any of its
Subsidiaries has any outstanding contract, agreement or other arrangement with
any of its affiliates (including the Association) or has engaged in any
transaction outside the ordinary course of business or inconsistent with past
practices with its affiliates since January 1, 1998.

                                    ARTICLE 5

                        CONDUCT AND TRANSACTIONS PRIOR TO
                        EFFECTIVE TIME; CERTAIN COVENANTS

         5.1 Access and Information. Subject to the restrictions contained in
confidentiality obligations to which such party is subject and subject to
preservation of attorney client and work product privileges (each party agreeing
to use reasonable best efforts to include the information described below), upon
reasonable notice, each of Company and Merger Partner shall (and shall cause
each of their respective Subsidiaries to) give to the other and to the
respective accountants, counsel and other representatives of such other party
reasonable access during normal business hours throughout the period prior to
the Effective Time to all of its and its Subsidiaries' properties, books,
contracts, commitments and records (including tax returns and insurance
policies) and shall permit them to consult with its and its Subsidiaries'
respective officers, employees, auditors (including, in connection with the
comfort letters referred to under Section 5.18, consulting with such party's
independent auditors and, subject to their concurrence, allow the review of the
work papers of such auditors relating thereto), actuaries, attorneys and agents;
provided, however, that any such investigation or consultation shall be
conducted in such a manner as not to interfere unreasonably with the business or
operations of the other party or its Subsidiaries. Subject to the proviso of the
immediately preceding sentence, Company shall permit Merger Partner and its
representatives access to all computer software programs that are material to
the conduct of the business of Company and the Company Subsidiaries for the
purpose of monitoring the implementation and progress of the Company's Year 2000
remediation plan. All confidential information provided pursuant to this Section
5.1 will be subject to the Confidentiality Agreement (the "Confidentiality
Agreement"), between Company and Merger Partner.

                                       33
<PAGE>

         5.2 Conduct of Business Pending Merger.

                  (a) Company agrees that from the date hereof to the Effective
Time, except as contemplated by this Agreement or as required by law or to the
extent that Merger Partner shall otherwise consent in writing (which consent
will not be unreasonably withheld or delayed), Company and the Company
Subsidiaries will operate their businesses only in the ordinary course, except
where the failure to so operate their businesses will not individually or in the
aggregate be material to Company and its Subsidiaries taken as a whole; and,
consistent with such operation, will use reasonable efforts consistent with past
practices to preserve their business organizations intact, to keep available to
them the goodwill of their agents, third party administrators, policyholders,
borrowers, customers and others with whom business relationships exist to the
end that their goodwill and ongoing business shall not be impaired in any
material respect at the Effective Time, and will further exercise reasonable
efforts to maintain their existing relationships with their employees in
general.

                  (b) Company agrees that from the date hereof to the Effective
Time, except as set forth in the Company Disclosure Letter and as otherwise
consented to by Merger Partner in writing (which consent will not be
unreasonably withheld or delayed) or as permitted, required or contemplated by
this Agreement or as required by law (and in such event reasonably prompt notice
will be provided to Merger Partner), (i) it will not change any provision of its
Restated Certificate of Incorporation or Bylaws; (ii) it will not make, declare
or pay any dividend or make any other distribution with respect to any shares of
capital stock, except regular quarterly cash dividends with respect to the
Company Common Stock (not to exceed $.25 per share per quarter); and (iii)
except (A) in connection with the issuance of shares of common stock, pursuant
to the exercise of presently outstanding employee or director stock options or
vesting of restricted stock or any other equity-based award in accordance with
its terms, (B) the grants of annual awards to directors in accordance with the
terms of the Phantom Restricted Stock Plan for Nonemployee Directors and (C) the
grant of awards of Options (as defined below) and Stock Awards to new hires in
the ordinary course of business consistent with past practice, it will not
directly or indirectly sell, issue, redeem, purchase or otherwise acquire, any
shares of its outstanding capital stock, change the number of shares of its
authorized or issued capital stock or issue or grant any option, warrant, call,
commitment, subscription, right to purchase or agreement of any character
relating to its authorized or issued capital stock or any securities convertible
into shares of such stock.

                  (c) Except as set forth in the Company Disclosure Letter, or
as permitted, required or contemplated by this Agreement, as required by law or
except in the ordinary course of business, Company agrees that from the date
hereof to the Effective Time it will not take or permit any Company Subsidiary
to take any of the following actions, except to the extent consented to by
Merger Partner in writing (which consent will not be unreasonably withheld or
delayed):

                  (i) except for refinancing of existing indebtedness,
         consistent with past practice, and for the taking down of additional
         indebtedness for borrowed money by Company and its finance Subsidiaries
         such that their respective leverage ratios are not materially increased
         above their target levels, enter into any agreement repre-


                                       34
<PAGE>

         senting an obligation for indebtedness for borrowed money or increase
         the principal amount of indebtedness under any existing agreement or
         assume, guarantee, endorse or otherwise become responsible for the
         obligations of any other individual, firm or corporation (except a
         guarantee of the obligation of a Company Subsidiary);

                  (ii) mortgage or pledge any of its properties or assets;

                  (iii) (A) take any action to amend or terminate any Company
         Employee Plan that would materially increase the cost of benefits
         thereunder or increase the compensation of any of its executive
         officers (other than increases which are in the aggregate in the
         ordinary course or in connection with promotions) or (B) adopt any
         other material plan, program, arrangement or practice providing new or
         increased benefits or compensation to its employees (provided, however,
         that this clause (iii) shall not prohibit the Company from implementing
         its Value Added Incentive Plan Restated 1999 as heretofore approved by
         the Compensation Committee of the Company Board of Directors or such
         other annual incentive plans for the 1999 fiscal year at the corporate,
         divisional or business unit levels);

                  (iv) materially amend or cancel or agree to the material
         amendment or cancellation of any agreement, treaty or arrangement which
         is material to the Company and the Company Subsidiaries on a
         consolidated basis, or enter into any new material agreement, treaty or
         arrangement which is material to Company and Company Subsidiaries on a
         consolidated basis or to Company Insurance Subsidiaries on a
         consolidated basis (other than the renewal of any existing agreements,
         treaties or arrangements);

                  (v) make any significant change in any accounting methods or
         systems of internal accounting controls, except as may be appropriate
         to conform to changes in statutory or regulatory accounting rules or
         generally accepted accounting principles or regulatory requirements
         with respect thereto;

                  (vi) pay, loan or advance (other than the payment of
         compensation, directors' fees or reimbursements of expenses in the
         ordinary course of business and other than as may be required by any
         agreement in effect as of the date hereof) any material amount to, or
         sell, transfer or lease any material properties or assets (real,
         personal or mixed, tangible or intangible) to, or enter into any
         material agreement or arrangement with, any of its officers or
         directors or any "affiliate" or "associate" of any of its officers or
         directors (as such terms are defined in Rule 405 promulgated under the
         Securities Act);

                  (vii) form or commence the operations of any business or any
         corporation, partnership, joint venture, marketing arrangement,
         association or other business organization or division thereof which in
         any case is material to the Company and its Subsidiaries taken as a
         whole;

                                       35
<PAGE>

                  (viii) (A) make or rescind any material express or deemed
         election relating to Taxes;

                         (B) settle or compromise any material claim, action, 
         suit, litigation, proceeding, arbitration, investigation, audit, or
         controversy relating to Taxes, other than the resolution of any matter
         (federal, state or local) related to the 1987 to 1993 tax years
         (including carryovers and/or carrybacks therefrom), which years are
         currently under consideration by the IRS, the Tax Court or the Joint
         Committee on Taxation; or

                         (C) change in any material respect its methods of 
         reporting income, deductions or accounting for federal income tax 
         those used in the preparation of its federal income Tax Return for the
         purposes from taxable year ending December 31, 1997, except as may be 
         required by applicable law;

                  (ix) pay, discharge, settle or satisfy any claims, liabilities
         or obligations (absolute, accrued, asserted or unasserted, contingent
         or otherwise) which are material to Company and the Company
         Subsidiaries as a whole, other than the payment, discharge or
         satisfaction of liabilities (i) reflected or reserved against in, or
         contemplated by, the financial statements (or the notes thereto) of
         Company included in the Company Reports or (ii) incurred since December
         31, 1997 in the ordinary course of business consistent with past
         practice;

                  (x) other than as would not be inconsistent with the Company's
         or its Subsidiaries' respective investment guidelines (or following
         consultation with the Merger Partner, consistent with industry
         standards), intentionally and materially alter the mix of investment
         assets of Company or the duration or credit quality of such assets;

                  (xi) other than consistent with past practice (or following
         consultation with Merger Partner, consistent with industry standards),
         intentionally and materially alter the profile of the insurance
         liabilities of the Company Insurance Subsidiaries or materially alter
         the pricing practices or policies of the Company Insurance
         Subsidiaries;

                  (xii) lease or otherwise dispose of any of its assets
         (including capital stock of the Company Subsidiaries) (except pursuant
         to contractual commitments in effect on the date hereof) which are
         material to Company and its Subsidiaries in the aggregate;

                  (xiii) make or agree to make any new capital expenditure or
         expenditures (except pursuant to contractual commitments in effect on
         the date hereof), or enter into any agreement or agreements providing
         for payments which, individually, are in excess of $20 million or, in
         the aggregate, are in excess of $100 million;

                  (xiv) permit the Company Subsidiaries to, except pursuant to
         contractual commitments in effect on the date hereof and disclosed in
         the Company Disclosure Letter, acquire or agree to acquire by merging
         or consolidating with, or by purchas-


                                       36
<PAGE>

         ing a substantial equity interest in or a substantial portion of the
         assets of, or by any other manner, any business or any corporation,
         partnership, association or other business organization or division
         thereof or otherwise acquire or agree to acquire any assets or
         securities in each case (i) (a) for any individual acquisition (except
         for any of Company's leveraged businesses) for an aggregate
         consideration in excess of $10 million, or (b) for any individual
         acquisition by any of Company's leveraged businesses in which the
         aggregate amount of ultimate equity capital employed (after
         releveraging the assets acquired to a ratio consistent with the
         relevant acquiring business' respective leverage ratio) is in excess of
         $10 million or (ii)(a) for all acquisitions (except for any acquisition
         by Company's leveraged businesses) for an aggregate consideration in
         excess of $100 million, or (b) for all acquisitions by Company's
         leveraged businesses, in which the aggregate amount of ultimate equity
         capital employed (after in each case re-leveraging the assets acquired
         to a ratio consistent with the relevant acquiring business' respective
         leverage ratio) is in excess of $100 million (excluding acquisitions
         approved in writing by Merger Partner) and (iii) where a filing under
         the HSR Act is required, except where Merger Partner and Company have
         agreed in writing that such action is not likely to (a) have a material
         effect on the ability of the parties to consummate the transactions
         contemplated by this Agreement or (b) delay the Effective Time by more
         than five business days; or

                  (xv) enter into any agreement to take any of the actions
         described in Section 5.2(b) or elsewhere in this Section 5.2(c).

                  Notwithstanding the foregoing, nothing contained herein shall
prohibit Company or any of its Subsidiaries from securitizing financial assets
in the ordinary course of business consistent with past practice.

                  (d) Company agrees that from the date hereof to the Effective
Time, Company shall, and shall cause the Company Subsidiaries to:

                  (i) promptly deliver to Merger Partner true and correct copies
         of any report, statement or schedule filed with the SEC subsequent to
         the date of this Agreement;

                  (ii) use reasonable efforts to maintain with financially
         responsible insurance companies insurance in such amounts and against
         such risks and losses as are customary for such party; and

                  (iii) at the request of Merger Partner, enter into a
         commercially reasonable "costless collar" arrangement with a
         counter-party reasonably acceptable to Company with respect to the
         equity portfolios (other than the holdings of the stock of Charles
         Schwab & Co., Inc.) of the Company and of the Company Insurance
         Subsidiaries.

                  (e) Merger Partner agrees that from the date hereof to the
Effective Time, except as contemplated by this Agreement or to the extent that
Company shall otherwise consent in writing (which consent shall not be
unreasonably withheld or delayed), it will, and will cause 


                                       37
<PAGE>

each Merger Partner Subsidiary to, operate its business only in the ordinary
course, except where the failure to so operate its business will not
individually or in the aggregate be material to Merger Partner and the Merger
Partner Subsidiaries taken as a whole.

                  (f) Merger Partner agrees that from the date hereof to the
Effective Time it will not take, or permit any Merger Partner Subsidiary to
take, any of the following actions, except to the extent consented to by Company
in writing (which consent will not unreasonably be withheld or delayed) or
permitted, required or contemplated by this Agreement:

                  (i) adopt or propose any change in its governing documents
         that would have any adverse impact on the transactions contemplated by
         this Agreement or which would amend or modify the terms or provisions
         of the capital stock of Merger Partner;

                  (ii) effect any combination, reclassification,
         recapitalization, division or similar transaction with respect to any
         class or series of capital stock of Merger Partner (other than a stock
         split, stock dividend or similar transaction contemplated by Section
         1.2(d));

                  (iii) merge or consolidate with any other person if such
         merger or consolidation could reasonably be expected to have a material
         impact on the ability of Merger Partner to consummate the transactions
         contemplated by this Agreement or to have any of the effects set forth
         in clause (A), (B), (C), (D) or (E) of subsection (vi) below;

                  (iv) make, declare, set aside or pay any dividend or other
         distribution with respect to shares of capital stock of Merger Partner,
         except the regular declaration and payment of cash or stock dividends
         with respect to the Merger Partner Common Stock (not to exceed, in the
         aggregate between the date of this Agreement and the Closing Date,
         $2.00 per share in cash and market value of Merger Partner Common
         Stock), and the regular declaration and payment of dividends with
         respect to Merger Partner Preferred Stock in accordance with its terms;

                  (v) issue, sell, grant, pledge or otherwise encumber any
         shares of the Merger Partner Common Stock, any other voting securities
         or any securities convertible into such shares, if any such action
         could, individually or in the aggregate, reasonably be expected to (A)
         require the consent of the stockholders of Merger Partner, (B) delay
         the date of mailing of the Proxy Statement by more than five business
         days, (C) if it were to occur after such date of mailing, require an
         amendment of the Proxy Statement which would delay the Company
         Stockholders' Meeting by more than five business days, (D) have a
         material adverse effect on the ability of Merger Partner to consummate
         the transactions contemplated by this Agreement, or (E) delay the
         Effective Time by more than five business days;

                  (vi) acquire any business or any corporation, partnership,
         joint venture, association or other business organization or division
         thereof, in each case if any such action could, individually or in the
         aggregate, reasonably be expected to (A) be mate-


                                       38
<PAGE>

         rial to Merger Partner, (B) delay by more than five business days the
         date of mailing of the Proxy Statement, (C) if it were to occur after
         such date of mailing, require an amendment of the Proxy Statement which
         would delay the Company Stockholders' Meeting by more than five
         business days, (D) have a material adverse effect on the ability of
         Merger Partner to consummate the transactions contemplated by this
         Agreement, or (E) delay the Effective Time by more than five business
         days;

                  (vii) except in the ordinary course of business, enter into
         any agreement representing an obligation for indebtedness for borrowed
         money or increase the principal amount of indebtedness under any
         existing agreement or assume, guarantee, endorse or otherwise become
         responsible for the obligations of any other individual, firm or
         corporation (except a guarantee of the obligation of a Subsidiary),
         except indebtedness incurred in connection with the financing and
         consummation of the transactions contemplated by this Agreement and
         additional indebtedness not in excess of $1.3 billion;

                  (viii) mortgage or pledge any of its properties or assets,
         except to the extent that the aggregate amount of assets subject to
         such mortgages and pledges is not material to Merger Partner;

                  (ix) except in the ordinary course of business, materially
         amend or cancel or agree to the amendment or cancellation of any
         agreement, treaty or arrangement, or enter into any new agreement,
         treaty or arrangement (other than the renewal of any existing
         agreements, treaties or arrangements), except and to the extent that
         the aggregate amount involved with respect to such agreements, treaties
         or arrangements is not material to Merger Partner;

                  (x) pay, loan or advance (other than the payment of
         compensation, directors' fees or reimbursements of expenses in the
         ordinary course of business and other than as may be required by any
         agreement in effect as of the date hereof) any amount to, or sell,
         transfer or lease any properties or assets (real, personal or mixed,
         tangible or intangible) to, or enter into any agreement or arrangement
         with, the Association, any of its officers or directors or any
         "affiliate" or "associate" of any of its officers or directors (as such
         terms are defined in Rule 405 promulgated under the Securities Act),
         except and to the extent that the aggregate amount involved with
         respect to such transactions is not material to Merger Partner;

                  (xi) except in the ordinary course of business, lease or
         otherwise dispose of any of its assets (including capital stock of the
         Merger Partner Subsidiaries) which are material to Merger Partner or
         the Merger Partner Subsidiaries, as the case may be, individually or in
         the aggregate;

                  (xii) make or agree to make any new capital expenditure or
         expenditures, or enter into any agreement or agreements providing for
         payments which, individually, are in excess of $100 million or, in the
         aggregate, are in excess of $1 billion

                                       39
<PAGE>

                  (xiii) except for acquisitions from the Association and as
         required by employee and agent benefit plans in the ordinary course of
         business, consistent with past practice, acquire directly or indirectly
         (including by or through its affiliates including the Association) any
         shares of Merger Partner Common Stock during the period beginning 22
         trading days prior to the Effective Time and ending at the Effective
         Time; or

                  (xiv) authorize any of, or commit or agree to take any of, the
         foregoing actions.

                  (g) Merger Partner agrees that from the date hereof to the
Effective Time, Merger Partner shall, and shall cause the Merger Partner
Subsidiaries to:

                  (i) promptly deliver to Company true and correct copies of any
         report, statement or schedule filed with the SEC subsequent to the date
         of this Agreement; and

                  (ii) use reasonable efforts to maintain with financially
         responsible insurance companies insurance in such amounts and against
         such risks and losses as are customary for such party.

                  (h) Company shall not, nor shall it knowingly permit any
Company Subsidiary to, nor shall it authorize or permit any officer, director or
employee of, or any duly authorized investment banker, attorney or other advisor
or representative or agent of, Company or any Company Subsidiary to, directly or
indirectly, (i) solicit, initiate or knowingly encourage the submission of any
Acquisition Proposal or (ii) participate in any discussions or negotiations
regarding, or furnish to any person any information with respect to, or
knowingly take any other action to facilitate the making of any proposal that
constitutes any Acquisition Proposal; provided, however, that nothing contained
in this Section 5.2(h) shall prohibit the Board of Directors of Company (and its
authorized representatives) from furnishing information to, or entering into
discussions or negotiations with, any person or entity that makes an unsolicited
Acquisition Proposal for a Company Acquisition (as defined below) if, and only
to the extent that (A) the Board of Directors of Company after consultation with
outside counsel, determines in good faith that in order for the Board of
Directors of Company to comply with its fiduciary duties to stockholders under
applicable law it should take such action, and (B) prior to taking such action,
Company receives from such person or entity an executed agreement in reasonably
customary form relating to the confidentiality of information to be provided to
such person or entity. Notwithstanding anything in this Agreement to the
contrary, Company shall (i) promptly advise Merger Partner orally and in writing
of (A) the receipt by it (or any of the other entities or persons referred to
above) after the date hereof of any Acquisition Proposal for a Company
Acquisition and (B) the material terms and conditions of such Acquisition
Proposal and (ii) give Merger Partner reasonable notice of the material terms
and conditions of an Acquisition Proposal prior to entering into a definitive
agreement with respect to such Acquisition Proposal, and negotiate with Merger
Partner to make such adjustments in the terms and conditions of this Agreement
as would enable Company to proceed with the transactions contemplated herein.
Without limiting the foregoing, it is understood that any violation of the
restrictions set forth in the first sentence of this Section 


                                       40
<PAGE>

5.2(h) by any officer or director of Company or any duly authorized investment
banker, attorney or other advisor, representative or agent of Company or any
Company Subsidiary shall be deemed to be a breach of this Section 5.2(h) by
Company. For purposes of this Agreement, "Acquisition Proposal" means any
inquiry, proposal or offer from any person relating to any direct or indirect
acquisition or purchase of a business that constitutes 15% or more of the net
revenues, net income or the assets of Company and Company Subsidiaries, taken as
a whole, or 15% or more of any class of equity securities of Company or any
Company Subsidiary, any tender offer or exchange offer that if consummated would
result in any person beneficially owning 15% or more of any class of equity
securities of Company or any Company Subsidiary, or any merger, consolidation,
business combination, recapitalization, liquidation, dissolution or similar
transaction involving Company or any Company Subsidiary, other than the
transactions contemplated by this Agreement. For purposes of this Agreement,
"Company Acquisition" means (i) a consolidation, exchange of shares or merger of
Company with any person, other than Merger Partner or one of its Subsidiaries,
and, in the case of a merger, in which Company shall not be the continuing or
surviving corporation, (ii) a merger of Company with a person, other than Merger
Partner or one of its Subsidiaries, in which Company shall be the continuing or
surviving corporation but the then outstanding shares of Company Common Stock
shall be changed into or exchanged for stock or other securities of Company or
any other person or cash or any other property or the shares of Company Common
Stock outstanding immediately before such merger shall after such merger
represent less than 50% of the voting stock of Company outstanding immediately
after the merger, (iii) the acquisition of beneficial ownership of 50% or more
of the voting stock of Company by any person (as such term is used under Section
13(d) of the Exchange Act), or (iv) a sale, lease or other transfer of 50% or
more of the assets of Company to any person, other than Merger Partner or one of
its Subsidiaries.

         5.3 Fiduciary Duties. Except as set forth below, the Board of Directors
of Company shall not (i) withdraw or modify in a manner materially adverse to
Merger Partner, the approval or recommendation by such Board of Directors of
this Agreement or the Merger, or (ii) approve, recommend or cause Company to
enter into any agreement with respect to any Acquisition Proposal.
Notwithstanding the foregoing, if Company receives an unsolicited Acquisition
Proposal for a Company Acquisition and the Board of Directors of Company
determines in good faith, following consultation with outside counsel, that it
is necessary to do so in order to comply with its fiduciary duties to
stockholders under applicable law, the Board of Directors may (w) withdraw or
materially modify in a manner adverse to Merger Partner its approval or
recommendation of this Agreement and the Merger, (x) approve or recommend such
Acquisition Proposal, (y) cause Company to enter into an agreement with respect
to such Acquisition Proposal or (z) terminate this Agreement pursuant to Section
7.1(b)(iv). If the Board of Directors of Company takes any action described in
clause (y) or (z) of the preceding sentence (other than entering into a
confidentiality agreement) or Merger Partner exercises its right to terminate
this Agreement under Section 7.1(c)(v) based on the Board of Directors of
Company having taken any action described in clause (w) or (x) of the preceding
sentence, Company shall, as a result of the taking of such action or such
termination (a "Fee Payment Event"), as applicable, pay to Merger Partner the
fees provided for under Section 5.4. Notwithstanding anything contained in this
Agreement to the contrary, any action by the Board of Directors of Company
permitted by this Section 5.3 shall not constitute a breach of this Agreement by
Company. Nothing contained in this Agree-


                                       41
<PAGE>

ment shall prevent the Company or its Board of Directors from complying with
Rule 14e-2 promulgated under the Exchange Act with regard to an Acquisition
Proposal.

         5.4 Certain Fees. If a Fee Payment Event occurs, Company shall pay
within three business days of a demand by Merger Partner, $300 million, payable
in same-day funds, as liquidated damages and not as a penalty. If Company fails
to timely pay to Merger Partner any amount due under this Section 5.4, Company
shall pay the costs and expenses (including reasonable legal fees and expenses)
in connection with any action, including the filing of any lawsuit or other
legal action, taken to collect payment, together with interest on the amount of
any unpaid fee at the publicly announced prime rate of Citibank, N.A. in effect
from time to time from the date such fee was required to be paid.

         5.5 Takeover Statutes. If any "fair price," "moratorium," "control
share acquisition," "business combination," "stockholder protection" or similar
antitakeover statute or regulation enacted under state or Federal law shall
become applicable to the Merger or any of the other transactions contemplated
hereby, each of Company and Merger Partner and the Board of Directors of each of
Company and Merger Partner shall grant such approvals and take such commercially
reasonable actions as are within its authority and consistent with its fiduciary
obligations to its stockholders as determined in good faith by such Board so
that the Merger and the other transactions contemplated hereby may be
consummated as promptly as practicable on the terms contemplated hereby and
otherwise use commercially reasonable efforts, subject to such fiduciary duties,
to eliminate or minimize the effects of such statute or regulation on the Merger
and the other transactions contemplated hereby.

         5.6 Consents. Company and Merger Partner will use reasonable best
efforts to obtain the written consent or approval of each and every governmental
authority and other regulatory body, the consent or approval of which shall be
required in order to permit Merger Partner, Sub and Company to consummate the
transactions contemplated by this Agreement. Company will use reasonable best
efforts to obtain the written consent or approval, in form and substance
reasonably satisfactory to Merger Partner, of each person whose consent or
approval shall be required in order to permit Merger Partner, Sub and Company to
consummate the transactions contemplated by this Agreement, except for any
contracts of Company as to which the failure to obtain any required written
consent or approval thereunder would not individually or in the aggregate result
in a Material Adverse Effect on Company. Merger Partner will use reasonable best
efforts to obtain the written consent or approval, in form and substance
reasonably satisfactory to Company, of each person whose consent or approval
shall be required in order to permit Merger Partner, Sub and Company to
consummate the transactions contemplated by this Agreement, except for any
contracts of Merger Partner as to which the failure to obtain any required
written consent or approval thereunder would not individually or in the
aggregate result in a Material Adverse Effect on Merger Partner.

         5.7 Further Assurances. Subject to the terms and conditions herein
provided, each of the parties hereto will promptly file and prosecute diligently
the applications and related documents required to be filed by such party with
the applicable regulatory authorities in order to effect the transactions
contemplated hereby, including filings under the HSR Act requesting early

                                       42
<PAGE>

termination of the applicable waiting period, filings under Foreign Competition
Laws and filings with state, federal and foreign banking and insurance
authorities. Each party hereto agrees to use all reasonable best efforts to
take, or cause to be taken, all action and to do, or cause to be done, all
things necessary, proper or advisable under applicable laws and regulations to
consummate and make effective the transactions contemplated by this Agreement
including, without limitation, each party shall use its best efforts to avoid
the entry of, or to have vacated or terminated, any decree, order or judgment
that would restrain, prevent or delay the Closing, including without limitation
defending through litigation on the merits any claim asserted in any court by
any party. In case at any time after the Effective Time any further action is
necessary or desirable to carry out the purposes of this Agreement, the proper
officers and directors of each corporation which is a party to this Agreement
shall take all such necessary action. Each of the parties hereto agrees to
defend vigorously against any actions, suits or proceedings in which such party
is named as defendant which seeks to enjoin, restrain or prohibit the
transactions contemplated hereby or seeks damages with respect to such
transactions.

         5.8 NYSE Listing. Merger Partner will use reasonable best efforts to
cause to be approved for listing on the NYSE, subject to official notice of
issuance, a sufficient number of shares of Merger Partner Common Stock to be
issued in the Merger.

         5.9 Notice; Efforts to Remedy. Each party hereto shall promptly give
written notice to the other parties hereto upon becoming aware of the occurrence
of any event which would cause or constitute a breach of any of the
representations, warranties or covenants of such party contained in this
Agreement and shall use reasonable best efforts to prevent or promptly remedy
the same. During the period from the date of this Agreement to the Effective
Time, Company and Merger Partner each shall cause one or more of its
representatives to confer on a regular and frequent basis with representatives
of the other and to report on the general status of its ongoing operations.
Company shall promptly notify Merger Partner of any change in each case on a
consolidated basis in the normal course of Company's or the Company
Subsidiaries' businesses or in the operation of its or their properties having a
Material Adverse Effect on Company and of the receipt by Company or the Company
Subsidiaries of notice of any governmental complaints, investigations or
hearings (or communications indicating that the same may be contemplated) or the
receipt by Company or the Company Subsidiaries of a notice of the institution or
the threat of litigation involving Company or any of the Company Subsidiaries
which, individually or in the aggregate, would have a Material Adverse Effect on
Company. Merger Partner shall promptly notify Company of any change in each case
on a consolidated basis in the normal course of Merger Partner's or the Merger
Partner Subsidiaries' businesses or in the operation of its or their properties
having a Material Adverse Effect on Merger Partner, and of the receipt by Merger
Partner or the Merger Partner Subsidiaries of notice of any governmental
complaints, investigations or hearings (or communications indicating that the
same may be contemplated) or the receipt by Merger Partner or the Merger Partner
Subsidiaries of a notice of the institution or the threat of litigation
involving Merger Partner or any of the Merger Partner Subsidiaries which,
individually or in the aggregate, would have a Material Adverse Effect on Merger
Partner.

                                       43
<PAGE>

         5.10 Registration Statement; Stockholder Approvals.

                  (a) As soon as is reasonably practicable after the execution
of this Agreement, Merger Partner shall prepare and file with the SEC the
Registration Statement (in which the Proxy Statement will be included as a
prospectus) and Company shall prepare and file with the SEC the Proxy Statement.
Merger Partner shall use reasonable best efforts to cause the Registration
Statement to become effective under the Securities Act as promptly as
practicable after such filing and shall take all commercially reasonable actions
required to be taken under any applicable state blue sky or securities laws in
connection with the issuance of the shares of Merger Partner Common Stock
pursuant to this Agreement. Each party hereto shall furnish all information
concerning it and the holders of its capital stock as the other party hereto may
reasonably request in connection with such actions.

                  (b) Company shall call a Stockholders' Meeting to be held as
soon as practicable after the date hereof for the purpose of voting upon the
Merger and this Agreement. Subject to Section 5.3, (i) Company shall mail the
Proxy Statement to its stockholders, (ii) the Board of Directors of Company
shall recommend to its stockholders the approval of the Merger and this
Agreement, and (iii) Company shall use reasonable best efforts to obtain such
stockholder approval. Without limiting the generality of the foregoing, Company
agrees that, subject to its rights pursuant to Section 5.3, its obligations
pursuant to this Section 5.10(b) shall not be affected by the commencement,
public proposal, public disclosure or communication to Company of any
Acquisition Proposal.

                  (c) Merger Partner shall present to its stockholders at its
general meeting of stockholders to be held on April 29, 1999, a proposal to
approve the use of general reserves of Merger Partner such that the shares of
Merger Partner Common Stock to be issued in the Merger shall be fully paid out
of such general reserves (the "Issuance"). (i) Merger Partner shall mail the
disclosure required under applicable law to its stockholders in connection with
such meeting, (ii) the Executive Board of Merger Partner shall take such action
with respect to its stockholders in support of the approval of the Issuance as
permitted by Dutch law, and (iii) Merger Partner shall use its reasonable best
efforts to obtain such stockholder approval.

         5.11 Expenses. If this Agreement is terminated for any reason without
breach by any party, each party hereto shall pay its own expenses incident to
preparing for, entering into, and carrying out this Agreement and to
consummating the Merger.

         5.12 Press Releases; Filings. Without the consent of the other parties,
none of the parties shall issue any press release or make any public
announcement with regard to this Agreement or the Merger or any of the
transactions contemplated hereby; provided, however, that nothing in this
Section 5.12 shall be deemed to (i) prohibit Company or Merger Partner from
making any disclosures, press releases or announcements relating to their
respective businesses or operations, or (ii) prohibit any party hereto from
making any disclosure which its counsel deems necessary or advisable in order to
fulfill such party's disclosure obligations imposed by law or the rules of any
national securities exchange or automated quotation system. Each of Company and
Merger Partner shall promptly notify the other of each report, schedule and
other 


                                       44
<PAGE>

document filed by it or any of its respective Subsidiaries with the SEC and of
any other document pertaining to the transactions contemplated hereby filed with
any other governmental authorities.

         5.13 Indemnification of Officers and Directors.

                  (a) From and after the Effective Time, Merger Partner shall
cause AEGON USA and the Surviving Corporation to indemnify, defend and hold
harmless to the fullest extent permitted under applicable law (excluding
personal conduct which is finally adjudicated by a court of competent
jurisdiction to constitute the commission of a crime by the relevant individual)
each person who is, or has been at any time prior to the Effective Time, an
officer or director of Company (or any Subsidiary or division thereof) and each
person who served at the request of Company as a director, officer, trustee or
fiduciary of another corporation, partnership, joint venture, trust, pension or
other employee benefit plan or enterprise (individually, an "Indemnified Party"
and, collectively, the "Indemnified Parties") against all losses, claims,
damages, liabilities, costs or expenses (including attorneys' fees), judgments,
fines, penalties and amounts paid in settlement in connection with any claim,
action, suit, proceeding or investigation arising out of or pertaining to acts
or omissions, or alleged acts or omissions, by them in their capacities as such,
whether commenced, asserted or claimed before or after the Effective Time. In
the event of any such claim, action, suit, proceeding or investigation (an
"Action"), (i) Merger Partner shall cause AEGON USA and the Surviving
Corporation to pay, as incurred, the fees and expenses of counsel selected by
the Indemnified Party, which counsel shall be reasonably acceptable to the
Surviving Corporation, in advance of the final disposition of any such Action to
the fullest extent permitted by applicable law, and, if required, upon receipt
of any undertaking required by applicable law, and (ii) Merger Partner shall
cause AEGON USA and the Surviving Corporation to cooperate in the defense of any
such matter; provided, however, the Surviving Corporation shall not be liable
for any settlement effected without its written consent (which consent shall not
be unreasonably withheld or delayed), and provided further, that Merger Partner
shall not be obligated pursuant to this Section 5.13 to cause AEGON USA and the
Surviving Corporation to pay the fees and disbursements of more than one counsel
for all Indemnified Parties in any single Action, unless, in the good faith
judgment of any of the Indemnified Parties, there is or may be a conflict of
interests between two or more of such Indemnified Parties, in which case there
may be separate counsel for each similarly situated group.

                  (b) The parties agree that the provisions relating to
exoneration of directors and the rights to indemnification, including provisions
relating to advances of expenses incurred in defense of any action or suit, in
the certificate of incorporation and bylaws of Company and its Subsidiaries with
respect to matters occurring through the Effective Time, shall survive the
Merger and shall continue in full force and effect for a period of six years
from the Effective Time; provided, however, that all rights to indemnification
in respect of any Action pending or asserted or claim made within such period
shall continue until the disposition of such Action or resolution of such claim.

                  (c) For a period of six years after the Effective Time, Merger
Partner and the Surviving Corporation shall cause to be maintained officers' and
directors' liability insurance 


                                       45
<PAGE>

covering the Indemnified Parties who are or at any time prior to the Effective
Time covered by the Company's existing officers' and directors' liability
insurance policies on terms substantially no less advantageous to the
Indemnified Parties than such existing insurance; provided, that after the third
year after the Effective Time, the Surviving Corporation shall not be required
to pay annual premiums in excess of 250% of the last annual premium paid by the
Company prior to the date hereof (the amount of which premium is set forth in
the Company Disclosure Letter), but in such case shall purchase as much coverage
as reasonably practicable for such amount.

                  (d) The rights of each Indemnified Party hereunder shall be in
addition to any other rights such Indemnified Party may have under the
certificate of incorporation or bylaws of the Company or any of its
Subsidiaries, under the DGCL or otherwise.

                  (e) In the event Merger Partner, the Surviving Corporation,
AEGON USA or any of their respective successors or assigns (i) consolidates with
or merges into any other person and shall not be the continuing or surviving
corporation or entity in such consolidation or merger or (ii) transfers all or
substantially all of its properties and assets to any person, then and in either
such case, proper provision shall be made so that the successors and assigns of
Merger Partner or the Surviving Corporation, or AEGON USA, as the case may be,
shall assume the obligations set forth in this Section 5.13.

                  (f) This Section 5.13 shall survive the Closing and is
intended to benefit Company, the Surviving Corporation and each of the
Indemnified Parties and his or her heirs and representatives (each of whom shall
be entitled to enforce this Section 5.13 against Merger Partner, AEGON USA or
the Surviving Corporation to the extent specified herein) and shall be binding
on all successors and assigns of Merger Partner, AEGON USA and the Surviving
Corporation.

         5.14 Tax Treatment. Merger Partner and Company agree to treat the
Merger as a reorganization within the meaning of Section 368(a) of the Code.
None of Merger Partner, Company or any of their respective Subsidiaries shall
take any action which would be reasonably likely to jeopardize qualification of
the Merger as a reorganization within the meaning of Section 368(a) of the Code.

         5.15 Employee Benefits.

                  (a) For a period of one year from the Effective Time, Merger
Partner and the Surviving Corporation shall honor all obligations and
commitments under the plans, programs, arrangements, practices and contracts
which are maintained by Company or any of the Company Subsidiaries or to which
Company or any Company Subsidiary is obligated to make contributions or which
provide benefits or compensation, including but not limited to executive
arrangements and "employee benefit plans" as defined in Section 3(1) of ERISA
and the Company Employee Plans and Company Foreign Plans, in each case in
accordance with their terms as in effect at the Effective Time, with only such
amendments as are required by applicable laws, or as provided by Section
5.15(c), or permitted by the terms thereof as in effect at the Effective Time,
and which do not decrease the benefits or otherwise adversely affect the rights
of participants (or their beneficiaries) thereunder. Notwithstanding anything
contained herein to the contrary, Merger Partner and the Surviving Corporation
agree to honor in accordance with their terms all 


                                       46
<PAGE>

benefits accrued or vested as of the Effective Time under the Company Employee
Plans and the Company Foreign Plans including any rights or benefits arising as
a result of the transactions contemplated by this Agreement (either alone or in
combination with any other event).

                  (b) Merger Partner shall take, and shall cause the Surviving
Corporation and its Subsidiaries and all other Affiliates of Merger Partner to
take, the following actions: (i) waive any limitations regarding pre-existing
conditions under any welfare or other employee benefit plan maintained by any of
them for the benefit of employees of Company or any of its subsidiaries (the
"Company Employees") or in which Company Employees participate after the
Effective Time, (ii) provide each Company Employee with credit for any
co-payments and deductibles paid prior to the Effective Time for the calendar
year in which the Effective Time occurs, in satisfying any applicable deductible
or out-of-pocket requirements under any welfare plans that such employees are
eligible to participate in after the Effective Time, and (iii) for all purposes
under all compensation and benefit plans and policies applicable to employees of
any of them, treat all service by Company Employees with Company or any of its
Subsidiaries or Affiliates of Company before the Effective Time as service with
Merger Partner and its affiliates, except to the extent such treatment would
result in duplication of benefits with respect to the same period of service.

                  (c) Effective as of the date set forth therein, the amendments
to the Company's Retirement Plan for Salaried U.S. Employees (the "Retirement
Plan"), the Supplemental Pension Plan, the SSP+ Supplemental Pension Plan and
Deferred Compensation Plan, described in Schedule 5.15 of the Company Disclosure
Letter, shall become effective and remain in effect without amendment, except as
required by law with respect to the Retirement Plan or such amendments which do
not decrease the benefits or otherwise adversely affect the rights of
participants (or their beneficiaries) thereunder.

         5.16 Equity-Based Awards. (a) Stock Options. At the Effective Time,
each option to purchase shares of Company Common Stock outstanding and
unexercised as of the Effective Time (the "Options") granted pursuant to the
Company's 1985 Stock Option and Stock Award Plan, 1995 Performance Stock Option
Plan and 1996 Stock Option and Award Plan as each has been amended from time to
time (collectively, the "Company Stock Plans") shall become fully vested and
immediately exercisable. Each holder of an Option outstanding as of the
Effective Time shall be entitled to receive out of the Exchange Fund, and shall
be paid out of the Exchange Fund in full satisfaction of such Option, a cash
payment in an amount in respect thereof equal to the product of (i) the excess
of the Consideration Amount over the exercise price of such Option, and (ii) the
number of shares of Company Common Stock subject to such Option at the Effective
Time, less any income or employment tax withholding required under the Code or
any provision of state, local or foreign law.

                  (b) TLSARs. At or after the Effective Time, each holder of a
tandem limited stock appreciation right ("TLSAR") outstanding as of the
Effective Time shall be entitled to elect to receive out of the Exchange Fund,
and shall be paid out of the Exchange Fund upon such election in full
satisfaction of such TLSAR, a cash payment in an amount in respect thereof equal
to the product of (i) the Change of Control Value (as defined in the applicable
Company Stock 


                                       47
<PAGE>

Plan and award agreement thereunder), over the exercise price of such TLSAR, and
(ii) the number of shares of Company Common Stock subject to such TLSAR at the
Effective Time, less any income or employment tax withholding required under the
Code or any provision of state, local or foreign law; provided, however that, to
the extent an Option with respect to which a related TLSAR has been granted
shall terminate upon exercise of the related TLSAR.

                  (c) Other Equity-Based Awards. At the Effective Time, each
phantom restricted stock award and phantom restricted share (collectively, the
"Stock Awards") granted pursuant to the Company's Stock Plans, the Company's
Phantom Restricted Stock Plan for Nonemployee Directors or pursuant to an
individual agreement (collectively, the "Award Arrangements") shall fully vest
and become immediately payable or distributable (except as set forth in Schedule
5.16(c) of the Company Disclosure Letter). At the Effective Time, each vested
Stock Award shall be canceled and terminated in accordance with its terms, and
the holder thereof shall receive out of the Exchange Fund in full satisfaction
of such Stock Award, a cash payment in an amount in respect thereof equal to the
product of (i) the Consideration Amount, and (ii) the number of shares of
Company Common Stock subject to such Stock Award at the Effective Time, less any
income or employment tax withholding required under the Code or any provision of
state, local or foreign law.

                  (d) All Options, TLSARs, Stock Awards and restricted Company
Common Stock outstanding as of the Effective Time and the exercise price thereof
(if any) shall have been adjusted prior to the Effective Time pursuant to the
terms of the applicable Company Stock Plan or Award Arrangement for the stock
dividend declared December 17, 1998.

                  (e) All restrictions on restricted Company Common Stock shall
lapse no later than the Effective Time and such shares shall be treated under
Article 1 of this Agreement as unrestricted shares of Company Common Stock,
provided the holder thereof shall be subject to any income or employment tax
withholding required under the Code or any provision of state, local or foreign
law.

         5.17 Rule 145. Company shall use commercially reasonable efforts to
cause each person who Company believes, at the time the Merger is submitted to a
vote of the stockholders of Company, is an "affiliate" for purposes of Rule 145
under the Securities Act, to deliver to Merger Partner on or prior to the
Closing Date a written agreement in terms satisfactory to Merger Partner, that
such person will not offer to sell, transfer or otherwise dispose of any of the
shares of Merger Partner Common Stock issued to such person pursuant to the
Merger, except in accordance with the applicable provisions of Rule 145, and
except in other transactions that are not in violation of the Securities Act.

         5.18 Comfort Letters. (a) Company shall use its reasonable best efforts
to cause its independent auditor to provide a letter dated the effective date of
the Registration Statement, with respect to certain financial information
regarding Company included in the Registration Statement, in form reasonably
satisfactory to Merger Partner and customary in scope and substance for letters
delivered by independent public accountants in connection with registration
statements 


                                       48
<PAGE>

similar to the Registration Statement. The costs of such letter shall be borne
equally by Company and Merger Partner.

                  (b) Merger Partner shall use its reasonable best efforts to
cause its independent auditor to provide a letter dated the effective date of
the Registration Statement, with respect to certain financial information
regarding Merger Partner included in the Registration Statement, in form
reasonably satisfactory to Company and customary in scope and substance for
letters delivered by independent public accountants in connection with
registration statements similar to the Registration Statement. The costs of such
letter shall be borne equally by Company and Merger Partner.

         5.19 Y2K Plans. (a) Company shall use its reasonable best efforts to
continue to execute the Company Y2K Plan in accordance with its terms.

                  (b) Merger Partner shall use its reasonable best efforts to
continue to execute the Merger Partner Y2K Plan in accordance with its terms.

         5.20 Compliance with 1940 Act. (a) The parties hereto acknowledge that
each of them has entered into this Agreement in reliance upon the benefits and
protections provided by Section 15(f) of the 1940 Act. Each of the parties
hereto shall not take, and each of them shall cause its affiliates not to take,
any action not contemplated by this Agreement that would have the effect,
directly or indirectly, of causing the requirements of any of the provisions of
Section 15(f) of the 1940 Act not to be met in respect of this Agreement and the
transactions contemplated hereby, and each of them shall not fail to take, and
each of them shall cause its affiliates not to fail to take, and after the
Closing Date shall not cause the Surviving Corporation to fail to take, any
action if the failure to take such action would have the effect, directly or
indirectly, of causing the requirements of any of the provisions of Section
15(f) of the 1940 Act not to be met in respect of this Agreement and the
transactions contemplated hereby. In that regard, each of the parties hereto
shall conduct its business and shall, subject to applicable fiduciary duties,
use its reasonable best efforts to cause each of its affiliates to conduct its
business so as to assure that, insofar as within the control of the parties
hereto or their respective affiliates:

                  (i) for a period of three years after the Closing Date, at
         least 75% of the members of the Board of Directors or trustees of each
         fund that is registered under the 1940 Act, and that continues after
         the Closing Date its existing or a replacement investment advisory
         contract with the Surviving Corporation or any affiliate of the
         Surviving Corporation, are not (A) "interested persons" of the
         investment manager of such fund after the Closing Date or (B)
         "interested persons" of the present investment manager of such fund;
         and

                  (ii) for a period of two years after the Closing Date, there
         shall not be imposed on any of the funds or sub-advisory funds that is
         registered under the 1940 Act an "unfair burden" as a result of the
         transactions contemplated by this Agreement, or any terms, conditions
         or understandings applicable thereto.

                                       49
<PAGE>

                  (b) The terms and quotations in this Section 5.20 shall have
the meanings set forth in Section 15(f) or Section 2(a)(19) of the 1940 Act.

                                    ARTICLE 6

                         CONDITIONS PRECEDENT TO MERGER

                           6.1 Conditions to Each Party's Obligations. The
                  respective obligations of each party to effect the Merger
                  shall be subject to the satisfaction on or prior to the
                  Closing Date of each of the following conditions:

                  (a) This Agreement and the Merger shall have been approved and
adopted by the affirmative vote or consent of the holders of at least a majority
of the outstanding shares of Company Common Stock.

                  (b) (i) All consents, authorizations, orders and approvals as
are required under applicable state insurance holding company laws in the United
States, and insurance change of control laws in Canada, and (ii) all additional
consents, authorizations, orders and approvals of (or filings or registrations
with) any governmental authority or other regulatory body required in connection
with the execution, delivery and performance of this Agreement which, in the
case of clause (ii) the failure to obtain would have a Material Adverse Effect
on Company or a Material Adverse Effect on Merger Partner shall have been
obtained and shall be in full force and effect and all statutory waiting periods
in respect thereof shall have expired without the imposition of any conditions
which would have, individually or in the aggregate, a Material Adverse Effect on
Company or a Material Adverse Effect on Merger Partner.

                  (c) Early termination shall have been granted or applicable
waiting periods shall have expired under the HSR Act.

                  (d) No governmental authority or other regulatory body
(including any court of competent jurisdiction) shall have enacted, issued,
promulgated, enforced or entered any law, rule, regulation, executive order,
decree, injunction or other order (whether temporary, preliminary or permanent)
which is then in effect and has the effect of making illegal, materially
restricting or in any way preventing or prohibiting the Merger.

                  (e) The Registration Statement shall have become effective
under the Securities Act and no stop order suspending the effectiveness of the
Registration Statement shall be in effect and no proceedings for such purpose,
shall be pending before or threatened by the SEC.

                  (f) The shares of Merger Partner Common Stock to be issued
pursuant to this Agreement shall have been authorized for listing on the NYSE,
subject to official notice of issuance.

         6.2 Conditions to Obligations of Company. The obligations of Company to
effect the Merger shall be subject to the satisfaction on or prior to the
Closing Date of each of the following conditions unless waived by Company:

                                       50
<PAGE>

                  (a) (i) The representations and warranties of Merger Partner
set forth in this Agreement which are qualified by a "Material Adverse Effect on
Merger Partner" qualification shall be true and correct in all respects as so
qualified at and as of the date of this Agreement and at and as of the Closing
Date as though made at and as of the Closing Date and (ii) the representations
and warranties of Merger Partner set forth in this Agreement which are not
qualified by a "Material Adverse Effect on Merger Partner" qualification shall
be true and correct at and as of the date of this Agreement and at and as of the
Closing Date as though made at and as of the Closing Date except for such
failures to be true and correct as would not, in the aggregate, have a Material
Adverse Effect on Merger Partner; provided, however, that, with respect to
clauses (i) and (ii) hereof, representations and warranties that are given as of
a particular date or period and relate solely to such particular date or period
shall be true and correct (in the manner set forth in clauses (i) or (ii), as
applicable), only as of such date or period.

                  (b) Merger Partner and Sub each shall have performed in all
material respects all covenants and agreements required to be performed by them
under this Agreement at or prior to the Closing Date.

                  (c) Merger Partner shall furnish Company with a certificate of
its appropriate officers as to compliance with the conditions set forth in
Sections 6.2(a) and (b).

                  (d) Company shall have received the opinion of Wachtell,
Lipton, Rosen & Katz, counsel to Company, in form and substance reasonably
satisfactory to Company, dated the Closing Date, a copy of which shall be
furnished to Merger Partner, to the effect that (i) the Merger will be treated
for federal income tax purposes as a reorganization within the meaning of
section 368(a) of the Code and (ii) no gain or loss will be recognized by the
stockholders of Company with respect to the receipt of Merger Partner Common
Stock in exchange for Company Common Stock pursuant to the Merger (except to the
extent of Cash Payments received and except with respect to cash received in
lieu of a fractional share interest in Merger Partner Common Stock). In
rendering such opinion, such counsel shall be entitled to receive and rely upon
representations of officers of Company and Merger Partner as to such matters as
such counsel may reasonably request. Notwithstanding the foregoing, this
condition shall not be a condition if Company shall have taken any action or
failed to take any action, which in any manner shall have been a cause of, or
resulted in, the failure to obtain the opinion referred to in this subsection
(d), other than failures to take action which were reasonable under the
circumstances.

         6.3 Conditions to Obligations of Merger Partner. The obligations of
Merger Partner to effect the Merger shall be subject to the satisfaction on or
prior to the Closing Date of each of the following conditions unless waived by
Merger Partner:

                  (a) (i) The representations and warranties of Company set
forth in this Agreement which are qualified by a "Material Adverse Effect on
Company" qualification shall be true and correct in all respects as so qualified
at and as of the date of this Agreement and at and as of the Closing Date as
though made at and as of the Closing Date and (ii) the representations and
warranties of Company set forth in this Agreement which are not qualified by a
"Material Adverse Effect on Company" qualification shall be true and correct at
and as of the date of this 


                                       51
<PAGE>

Agreement and at and as of the Closing Date as though made at and as of the
Closing Date except for such failures to be true and correct as would not, in
the aggregate, have a Material Adverse Effect on Company; provided, however,
that, with respect to clauses (i) and (ii) hereof, representations and
warranties that are given as of a particular date or period and relate solely to
such particular date or period shall be true and correct (in the manner set
forth in clauses (i) or (ii), as applicable), only as of such date or period.

                  (b) Company shall have performed in all material respects all
covenants and agreements required to be performed by it under this Agreement at
or prior to the Closing Date.

                  (c) Company shall furnish Merger Partner with a certificate of
its appropriate officers as to compliance with the conditions set forth in
Sections 6.3(a) and (b).

                  (d) Merger Partner shall have received the opinion of LeBoeuf,
Lamb, Greene & MacRae, L.L.P., counsel to Merger Partner, in form and substance
reasonably satisfactory to Merger Partner, dated the Closing Date, a copy of
which shall be furnished to Company, to the effect that the Merger will be
treated for federal income tax purposes as a reorganization within the meaning
of section 368(a) of the Code. In rendering such opinion, such counsel shall be
entitled to receive and rely upon representations of officers of Company and
Merger Partner as to such matters as such counsel may reasonably request.
Notwithstanding the foregoing, this condition shall not be a condition if Merger
Partner shall have taken any action or failed to take any action, which in any
manner shall have been a cause of, or resulted in, the failure to obtain the
opinion referred to in this subsection (d), other than failures to take action
which were reasonable under the circumstances.

                                    ARTICLE 7

                    TERMINATION AND ABANDONMENT OF THE MERGER

         7.1 Termination. This Agreement may be terminated at any time prior to
the Effective Time, whether before or after the approval by the stockholders of
Company:

                  (a) by the mutual written consent of Merger Partner and
Company;

                  (b) by Company if:

                  (i) the Merger is not consummated on or before December 31,
         1999 (or such later date as shall have been approved by Merger Partner
         and Company), unless the failure of such occurrence shall be due to the
         failure of Company to perform or observe the covenants and agreements
         hereof to be performed or observed by it at or before the Effective
         Time;

                  (ii) events occur which render impossible the satisfaction of
         one or more of the conditions set forth in Sections 6.1 and 6.2 and
         such conditions are not waived by Company, unless the failure of such
         occurrence shall be due to the failure of Com-


                                       52
<PAGE>

         pany to perform or observe the covenants and agreements hereof to be
         performed or observed by it at or before the Effective Time;

                  (iii) Company is permanently enjoined or restrained by any
         governmental authority or other regulatory body (including any court of
         competent jurisdiction), such injunction or restraining order prevents
         the Merger and such injunction or restraining order shall have become
         final and nonappealable;

                  (iv) the Board of Directors of Company shall have exercised
         any of its rights set forth in the second sentence of Section 5.3;

                  (v) the stockholders of Company do not approve this Agreement
         and the Merger at the Stockholders' Meeting (including adjournments and
         postponements thereof); or

                  (vi) on the date on which the Closing would otherwise occur,
         the Share Price shall be less than $61.88; but only if (i) Company has
         given Merger Partner at least three business days' prior written notice
         of Company's intent to effect such termination pursuant to this Section
         7.1(b)(vi), and (ii) during such three business day period, Merger
         Partner shall not have elected to increase the Exchange Ratio such that
         the Exchange Ratio as so increased multiplied by the Share Price shall
         equal $50.505 (or such other number as Company and Merger Partner may
         agree);

                  (c) by Merger Partner if:

                  (i) the Merger is not consummated on or before December 31,
         1999 (or such later date as shall have been approved by Company and
         Merger Partner), unless the failure of such occurrence shall be due to
         the failure of Merger Partner or Sub to perform or observe the
         covenants and agreements hereof to be performed or observed by them at
         or before the Effective Time;

                  (ii) events occur which render impossible the satisfaction of
         one or more of the conditions set forth in Sections 6.1 and 6.3 and
         such conditions are not waived by Merger Partner, unless the failure of
         such occurrence shall be due to the failure of Merger Partner or Sub to
         perform or observe the covenants and agreements hereof to be performed
         or observed by them at or before the Effective Time;

                  (iii) Merger Partner is permanently enjoined or restrained by
         any governmental authority or other regulatory body (including any
         court of competent jurisdiction), such injunction or restraining order
         prevents the Merger and such injunction or restraining order shall have
         become final and nonappealable;

                  (iv) the stockholders of Company do not approve this Agreement
         and the Merger at the Stockholders' Meeting (including adjournments and
         postponements thereof); or

                                       53
<PAGE>

                  (v) the Board of Directors of Company shall have withdrawn or
         materially modified in a manner adverse to Merger Partner its
         recommendation of this Agreement and the Merger or the Board of
         Directors shall have approved or recommended another Acquisition
         Proposal; or

                  (vi) on the date on which the Closing would otherwise occur,
         the Share Price shall be greater than $128.52; but only if (i) Merger
         Partner has given Company at least three business days' prior written
         notice of Merger Partner's intent to effect such termination pursuant
         to this Section 7.1(c)(vi) and (ii) during such three business day
         period, Company shall not have elected to decrease the Exchange Ratio
         such that the Exchange Ratio as so decreased multiplied by the Share
         Price shall equal $58.695 (or such other number as Company and Merger
         Partner may agree).

         7.2 Effect of Termination and Abandonment. In the event of the
termination and abandonment of this Agreement under Section 7.1, this Agreement
shall become void and have no effect, without any liability on the part of any
party or its directors, officers or stockholders except (i) as provided in the
third sentence of Section 5.1, and in Sections 5.4 and 5.11 and (ii) to the
extent that such termination results from the willful breach by any party hereto
of any covenant or agreement hereunder.

                                    ARTICLE 8

                                  MISCELLANEOUS

         8.1 Waiver and Amendment. Any term or provision of this Agreement may
be waived in writing at any time by the party which is, or whose stockholders
are, entitled to the benefits thereof, and any term or provision of this
Agreement may be amended or supplemented at any time by action of the respective
Boards of Directors (or its authorized representative) of Merger Partner or
Company without action of the stockholders, whether before or after the
Stockholders' Meeting; provided, however, that after approval of the
stockholders of Company, except as provided in Sections 7.1 (b)(vi) and 7.1
(c)(vi) no such amendment shall reduce the amount or change the form of the
consideration to be delivered to Company's stockholders as contemplated by this
Agreement or otherwise materially adversely affect the interests of such
stockholders unless such amendment is approved by Company's stockholders. No
amendment to this Agreement shall be effective unless it has been executed by
Company, Merger Partner and Sub.

         8.2 Non-Survival of Representations, Warranties and Agreements. Except
for the agreements contained in Sections 1.2, 1.3, 1.4, 1.5, 1.6, 1.9, 5.7,
5.13, 5.14, 5.15 and 5.16 and Article 8, none of the representations, warranties
and agreements of Company, Merger Partner or Sub in this Agreement, or in any
instrument or certificate delivered pursuant to this Agreement, shall survive
the Merger nor shall their respective stockholders, directors or officers have
any liability to the other after the Effective Time on account of any breach of
warranty or failure or the incorrectness of any of the representations or
warranties contained herein or in any certificate or other instrument delivered
pursuant to this Agreement. The sole right and remedy arising from a
misrepresentation or breach of warranty or from the failure of any of the
conditions of the 


                                       54
<PAGE>

Merger to be met shall be termination of this Agreement by the aggrieved party
and the remedies except that, as provided in Section 7.2 nothing herein shall
relieve any party from any liability for any willful and material breach by such
party of any of its covenants or agreements set forth in this Agreement.

         8.3 Notices. All notices or other communications which are required or
permitted hereunder shall be in writing and sufficient if delivered personally,
telecopied (if confirmed) or sent by registered or certified mail, postage
prepaid, return receipt requested, addressed as follows:

                  If to Company:

                          Transamerica Corporation
                          The Transamerica Pyramid
                          600 Montgomery Street, 24th Floor
                          San Francisco, California  94111
                          Attention:  Shirley H. Buccieri
                           Telecopy No.:  (415) 983-4164

                  With a copy to:

                          Wachtell, Lipton, Rosen & Katz
                          51 West 52nd Street
                          New York, New York  10019
                          Attention:  Daniel A. Neff
                          Telecopy No.:  (212) 403-2000

                  If to Merger Partner:

                    (via mail):

                          AEGON N.V.
                          P.O. Box 202
                          2501 CE The Hague
                          The Netherlands
                          Attention:  Mr. Kees J. Storm
                           Telecopy No.:  (31-70) 347-7929

                    (via hand delivery):

                          AEGON N.V.
                          Mariahoeveplein 50
                          2591 TV The Hague
                          The Netherlands
                          Attention:  Mr. Kees J. Storm
                          Telecopy No.:  (31-70) 347-7929

                                       55
<PAGE>

                           and to:

                          AEGON USA, Inc.
                          4333 Edgewood Road, NE
                          Cedar Rapids, Iowa  52499
                          Attention:  Mr. Craig D. Vermie
                           Telecopy No.:  (319) 369-2218

                  With a copy to:

                          LeBoeuf, Lamb, Greene & MacRae, L.L.P.
                          125 West 55th Street
                          New York, New York  10019-5389
                          Attention:  Mr. Donald B. Henderson, Jr.
                          Telecopy No.:  (212) 424-8500

                  If to Sub:
                          Tony Merger Corp.
                          c/o AEGON USA, Inc.
                          4333 Edgewood Road, NE
                          Cedar Rapids, Iowa  52499
                          Attention:  Mr. Craig D. Vermie
                          Telecopy No.:  (319) 369-2218

                  With a copy to:

                          LeBoeuf, Lamb, Greene & MacRae, L.L.P.
                          125 West 55th Street
                          New York, New York  10019-5389
                          Attention:  Mr. Donald B. Henderson, Jr.
                          Telecopy No.:  (212) 424-8500

         8.4 Descriptive Headings; Interpretation. The descriptive headings are
for convenience of reference only and shall not control or affect the meaning or
construction of any provision of this Agreement. When a reference is made in
this Agreement to Sections, such reference shall be to a Section of this
Agreement unless otherwise indicated. Whenever the words "include," "includes"
or "including" are used in this Agreement, they shall be deemed to be followed
by the words "without limitation." The words "hereof," "herein," "hereby" and
other words of similar import refer to this Agreement as a whole unless
otherwise indicated. The words "to the knowledge of the Company" or "to
Company's knowledge" and any words of similar import shall mean that any one of
the persons listed on Exhibit A has actual knowledge of the matter. The words
"to the knowledge of Merger Partner" or "to Merger Partner's knowledge" and any
words of similar import shall mean that any one of the persons listed on Exhibit
B has actual knowledge of the matter.

                                       56
<PAGE>

         8.5 Counterparts. This Agreement may be executed in any number of
counterparts, and each such counterpart shall be deemed to be an original
instrument, but all such counterparts together shall constitute but one
agreement. This Agreement shall become effective when one or more counterparts
have been signed by each of the parties and delivered to the other parties, it
being understood that the parties need not sign the same counterpart.

         8.6 Entire Agreement. This Agreement, the Company Disclosure Letter,
the Merger Partner Disclosure Letter and the Confidentiality Agreement contain
the entire agreement between Merger Partner, Sub and Company with respect to the
Merger, and supersede all prior arrangements or understandings with respect to
the subject matter hereof. Except as otherwise contemplated in the covenants
listed in Section 8.2 (which covenants shall be enforceable by the person or
persons affected thereby following the Effective Time), this Agreement is not
intended to confer upon any person other than the parties hereto any rights or
remedies hereunder.

         8.7 GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK (WITHOUT REGARD TO ANY
APPLICABLE CONFLICTS OF LAW PROVISIONS THEREOF).

         8.8 Severability. If any term or other provision of this Agreement is
invalid, illegal or incapable of being enforced by any rule of law or public
policy, all other conditions and provisions of this Agreement shall nevertheless
remain in full force and effect so long as the economic or legal substance of
the transactions contemplated hereby are not affected in any manner materially
adverse to any party. Upon such determination that any term or other provision
is invalid, illegal or incapable of being enforced, the parties shall negotiate
in good faith to modify this Agreement so as to effect the original intent of
the parties as closely as possible in a mutually acceptable manner in order that
the transactions be consummated as originally contemplated to the fullest extent
possible.

         8.9 Enforcement of Agreement. The parties agree that irreparable damage
would occur in the event that any of the provisions of this Agreement were not
performed in accordance with their specific terms or were otherwise breached. It
is accordingly agreed that the parties shall be entitled to an injunction or
injunctions to prevent breaches of this Agreement and to enforce specifically
the terms and provisions hereof in any court of the United States or any state
having jurisdiction, this being in addition to any other remedy to which they
are entitled at law or in equity.

         8.10 Assignment. Neither this Agreement nor any of the rights,
interests or obligations hereunder shall be assigned by any of the parties
hereto (whether by operation of law or otherwise) without the prior written
consent of the other parties, and any attempt to make any such assignment
without such consent shall be null and void. Subject to the preceding sentence,
this Agreement will be binding upon, inure to the benefit of and be enforceable
by the parties hereto and their respective successors and assigns.

         8.11 Obligation of Merger Partner. Whenever this Agreement requires Sub
(or its successors, including the Surviving Corporation) to take any action,
such requirement shall be 


                                       57
<PAGE>

deemed to include an undertaking on the part of Merger Partner to cause Sub (or
such successors) to take such action and a guarantee of the performance thereof.

         8.12 CONSENT TO JURISDICTION; SERVICE OF PROCESS.

                  (a) EACH PARTY IRREVOCABLY CONSENTS AND AGREES THAT ANY LEGAL
ACTION, SUIT OR PROCEEDING BY OR AGAINST IT WITH RESPECT TO ITS RIGHTS,
OBLIGATIONS OR LIABILITIES UNDER THIS AGREEMENT OR ANY OTHER AGREEMENT EXECUTED
IN CONNECTION WITH THIS AGREEMENT SHALL BE BROUGHT BY SUCH PARTY ONLY IN THE
UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, AND EACH
PARTY HEREBY CONSENTS TO THE JURISDICTION OF SUCH COURT, OR, IF (BUT ONLY IF)
SUCH COURT DOES NOT HAVE SUBJECT MATTER JURISDICTION OVER SUCH ACTION, SUIT OR
PROCEEDING (INCLUDING, WITHOUT LIMITATION, CLAIMS FOR INTERIM RELIEF,
COUNTERCLAIMS, ACTIONS WITH MULTIPLE DEFENDANTS AND ACTIONS IN WHICH SUCH PARTY
IS IMPLED SUCH OTHER COURT IN THE CITY AND STATE OF NEW YORK AS WOULD HAVE
SUBJECT MATTER JURISDICTION AND EACH PARTY HEREBY CONSENTS TO THE JURISDICTION
OF SUCH COURT; PROVIDED, HOWEVER, THAT NOTHING CONTAINED HEREIN SHALL LIMIT THE
RIGHT OF COMPANY OR ANY THIRD PARTY BENEFICIARY HEREUNDER TO COMMENCE ANY LEGAL
ACTION AGAINST MERGER PARTNER AND ITS AFFILIATES IN ANY COURT OF COMPETENT
JURISDICTION IN THE NETHERLANDS OR ELSEWHERE TO ENFORCE THE JUDGMENTS AND ORDERS
OF ANY OTHER COURT. EACH PARTY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT
THAT IT MAY HAVE TO A JURY TRIAL IN ANY LEGAL ACTION, SUIT OR PROCEEDING WITH
RESPECT TO, OR ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT OR ANY OTHER
AGREEMENT EXECUTED IN CONNECTION WITH THIS AGREEMENT.

                  (b) MERGER PARTNER HEREBY IRREVOCABLY DESIGNATES LEBOEUF,
LAMB, GREENE & MACRAE, LLP (IN SUCH CAPACITY THE "PROCESS AGENT"), WITH AN
OFFICE AT 125 WEST 55TH STREET, NEW YORK, NEW YORK 10019 AS ITS DESIGNEE,
APPOINTEE AND AGENT TO RECEIVE, FOR AND ON ITS BEHALF SERVICE OF PROCESS IN SUCH
JURISDICTION IN ANY LEGAL ACTION OR PROCEEDINGS WITH RESPECT TO THIS AGREEMENT
OR ANY OTHER AGREEMENT EXECUTED IN CONNECTION WITH THIS AGREEMENT, AND SUCH
SERVICE SHALL BE DEEMED COMPLETE UPON DELIVERY THEREOF TO THE PROCESS AGENT,
PROVIDED THAT IN THE CASE OF ANY SUCH SERVICE UPON THE PROCESS AGENT, THE PARTY
EFFECTING SUCH SERVICE SHALL ALSO DELIVER A COPY THEREOF TO MERGER PARTNER IN
THE MANNER PROVIDED IN SECTION 8.3. MERGER PARTNER SHALL TAKE ALL SUCH ACTION AS
MAY BE NECESSARY TO CONTINUE SAID APPOINTMENT IN FULL FORCE AND EFFECT OR TO
APPOINT ANOTHER AGENT SO THAT MERGER PARTNER WILL AT ALL TIMES HAVE AN AGENT FOR
SERVICE OF PROCESS FOR THE ABOVE PURPOSES IN NEW YORK. IN THE EVENT OF THE
TRANSFER OF ALL OR SUBSTANTIALLY ALL OF THE ASSETS AND BUSINESS OF THE PROCESS
AGENT TO ANY OTHER CORPORATION BY CONSOLI-


                                       58
<PAGE>

DATION, MERGER, SALE OF ASSETS OR OTHERWISE, SUCH OTHER CORPORATION SHALL BE
SUBSTITUTED HEREUNDER FOR THE PROCESS AGENT WITH THE SAME EFFECT AS IF NAMED
HEREIN IN PLACE OF LEBOEUF, LAMB, GREENE & MACRAE, LLP. MERGER PARTNER FURTHER
IRREVOCABLY CONSENTS TO THE SERVICE OF PROCESS OUT OF ANY OF THE AFOREMENTIONED
COURTS IN ANY SUCH ACTION OR PROCEEDING BY THE MAILING OF COPIES THEREOF BY
REGISTERED AIRMAIL, POSTAGE PREPAID, TO SUCH PARTY AT ITS ADDRESS SET FORTH IN
THIS AGREEMENT, SUCH SERVICE OF PROCESS TO BE EFFECTIVE UPON ACKNOWLEDGMENT OF
RECEIPT OF SUCH REGISTERED MAIL. NOTHING HEREIN SHALL AFFECT THE RIGHT OF ANY
PARTY TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY APPLICABLE LAW. MERGER
PARTNER EXPRESSLY ACKNOWLEDGES THAT THE FOREGOING WAIVER IS INTENDED TO BE
IRREVOCABLE UNDER THE LAWS OF THE STATE OF NEW YORK AND OF THE UNITED STATES OF
AMERICA.

                                    ARTICLE 9

                                   DEFINITIONS

         9.1 Definitions. For purposes of this Agreement, the following terms
shall have the following meanings:

         "Consideration Amount" shall mean $78.

         "Foreign Competition Laws" shall mean foreign statutes, rules,
regulations, orders, decrees, administrative and judicial doctrines, and other
foreign Laws that are designed or intended to prohibit, restrict or regulate
actions having the purpose or effect of monopolization, lessening of competition
or restraint of trade.

         "Laws" shall mean any federal, state, local or foreign law, statute,
ordinance, rule, regulation, order, judgment or decree, administrative order or
decree, administrative or judicial decision, and any other executive or
legislative proclamation.

         "Liens" shall mean all pledges, claims, liens, charges, encumbrances
and security interests of any kind or nature whatsoever.

         "Person" shall mean an individual, a corporation, a partnership, an
association, a trust or other entity or organization.

         "Subsidiary" shall mean, with respect to any party, any corporation or
other organization, whether incorporated or unincorporated, of which (i) such
party or any other subsidiary of such party is a general partner or (ii) at
least a majority of the securities or other interests having by their terms
ordinary voting power to elect a majority of the Board of Directors or others
performing similar functions with respect to such corporation or other
organization or at least a majority of the value of the outstanding equity is
directly or indirectly owned or controlled by 


                                       59
<PAGE>

such party or by any one or more of its subsidiaries, or by such party and one
or more of its subsidiaries.

         "Tax" shall mean any federal, state, county, local or foreign taxes,
charges, fees, levies, or other assessments, including all net income, gross
income, premiums, sales and use, ad valorem, transfer, gains, profits, windfall
profits, excise, franchise, real and personal property, gross receipts, capital
stock, production, business and occupation, employment, disability, payroll,
license, estimated, stamp, custom duties, severance or withholding taxes, other
taxes or similar charges of any kind whatsoever imposed by any governmental
entity, whether imposed directly on a Person or resulting under Treasury
Regulation Section 1.1502-6 (or any similar provision of state, local or foreign
Law), as a transferee or successor, by contract or otherwise and includes any
interest and penalties (civil or criminal) on or additions to any such taxes or
in respect of a failure to comply with any requirement relating to any Tax
Return.

         "Tax Return" shall mean a report, return or other information required
to be supplied to a governmental entity with respect to Taxes including, where
permitted or required, combined or consolidated returns for any group of
entities.

         9.2 Certain Defined Terms Index. For purposes of this Agreement, the
following terms shall have their respective meaning as set forth in the Section
indicated below:

DEFINED TERM                                            SECTION

Acquisition Proposal                                     5.2(h)
Action                                                   5.13(a)
Adjusted Stock Consideration Amount                      1.2(c)(vi)
AEGON USA                                                1.9
Agreement                                                Introductory
                                                            Paragraph
ASE                                                      1.2(c)(iii)
Association                                              4.4
Award Arrangements                                       5.16(c)
Cash Payment                                             1.2(c)
Certificate                                              1.2(c)
Certificate of Merger                                    1.1(a)
Closing                                                  2.1
Closing Date                                             2.1
Code                                                     1.7
Company                                                  Introductory
                                                            Paragraph
Company Acquisition                                      5.2(h)
Company Common Stock                                     1.2(b)
Company Consolidated Financial Statements                3.6(b)
Company Controlled Group Liability                       3.13(b)
Company Disclosure Letter                                Introductory
                                                            Paragraph to Art. 3


                                       60
<PAGE>

Company Employee Plans                                   3.13(a)
Company Employees                                        5.15(b)
Company Foreign Plan                                     3.13(a)
Company Insurance Subsidiary                             3.7
Company Reports                                          3.6(a)
Company Separate Accounts                                3.24
Company Stock Plans                                      5.16(a)
Company Subsidiaries                                     3.1(a)
Company Y2K Plan                                         3.22(b)
Confidentiality Agreement                                5.1
DGCL                                                     Recitals
Dissenting Shares                                        1.8
Effective Time                                           1.1(a)
Environmental Law                                        3.17(a)
ERISA                                                    3.13(a)
Excess Change Amount                                     1.2(c)(v)
Exchange Act                                             3.6(a)
Exchange Agent                                           1.3(a)
Exchange Fund                                            1.3(a)
Exchange Ratio                                           1.2(c)(vii)
Fee Payment Event                                        5.3
Foreign Plan                                             4.13(a)
Funds                                                    3.25(a)
Goldman Sachs                                            3.15
Governmental Entity                                      3.5
HSR Act                                                  3.5
Indemnified Parties                                      5.13(a)
Initial Price                                            1.2(c)(i)
Insurance Laws                                           3.16(a)
Insurance Product(s)                                     3.9(f)(i)
Intellectual Property                                    3.23
IRS                                                      3.9(c)
Issuance                                                 5.10(c)
Material Adverse Effect on Company                       3.1(a)
Material Adverse Effect on Merger Partner                4.1(a)
Merger                                                   Recitals
Merger Partner                                           Introductory
                                                            Paragraph
Merger Partner Common Stock                              1.2(c)
Merger Partner Consolidated
   Financial Statements                                  4.6(b)
Merger Partner Controlled Group Liability                4.13(b)
Merger Partner Disclosure Letter                         Introductory
                                                            Paragraph to Art. 4
Merger Partner Employee Plans                            4.13(a)



                                       61
<PAGE>

Merger Partner Insurance Subsidiary                      4.7
Merger Partner Preferred Stock                           4.2
Merger Partner Reports                                   4.6(a)
Merger Partner Subsidiary                                4.1(a)
Merger Partner Supplemental Disclosure Letter            4.5(b)
Merger Partner Y2K Plan                                  4.20(b)
1940 Act                                                 3.24
NYSE                                                     3.5(b)
Options                                                  5.16(a)
Percentage Price Change                                  1.2(c)(iv)
Process Agent                                            8.12(b)
Proxy Statement                                          3.12
Registration Statement                                   3.12
Retirement Plan                                          5.15(c)
SEC                                                      3.6(a)
Securities Act                                           3.6(a)
Share Price                                              1.2(c)(iii)
Significant Subsidiary                                   3.3
Stock Awards                                             5.16(c)
Stock Consideration Amount                               1.2(c)(ii)
Stockholders' Meeting                                    3.12
Sub                                                      Introductory
                                                            Paragraph
Supplemental Disclosure Letter                           3.5
Surviving Corporation                                    1.1(a)
TLSAR                                                    5.16(b)
Violation                                                3.5(a)(i)



                                       62
<PAGE>


                  IN WITNESS WHEREOF, each of the parties hereto has caused this
Agreement to be executed and delivered by its respective duly authorized
officers, all as of the date first above written.

                                        AEGON N.V.


                                        By: 
                                            ------------------------------------
                                            Name:  Donald J. Shepard
                                            Title: Member of Executive Board
                                           

                                        TONY MERGER CORP.


                                        By: 
                                            ------------------------------------
                                            Name:  Patrick S. Baird
                                            Title: President


                                        TRANSAMERICA CORPORATION


                                        By: 
                                            ------------------------------------
                                            Name:  Frank C. Herringer
                                            Title: Chairman and Chief Executive
                                                     Officer




                                       63
<PAGE>


                                     ANNEX A

                       EXCHANGE RATIO COMPUTATION EXAMPLES
                       -----------------------------------

                  For purposes of clarification, the following examples show the
manner in which the Exchange Ratio is computed in accordance with Section 1.2.


- --------------------------------------------------------------------------------
EXAMPLE I (clause (B) of Section 1.2(c)(vii) applies)
- ---------

Assumptions
- ------------

Initial Price  = $95.20

Share Price = $123.76

Calculations
- -------------
                          $123.76 - $95.20       
Percentage Price Change = ----------------  = 0.3
                              $95.20             

Excess Change = 0.3 - 0.2 = 0.1

Adjusted Stock Consideration Amount = $54.60 + 1/2[$54.60 * 0.1] = 
                                                       $54.60 + $2.73 = $57.33

                  $57.33
Exchange Ratio = --------- = 0.46324
                 $123.76
     
- --------------------------------------------------------------------------------


- --------------------------------------------------------------------------------
EXAMPLE II (clause (D) of Section 1.2(c)(vii) applies)
- ----------

Assumptions
- ------------

Initial Price  = $95.20

Share Price = $66.64

Calculations
- ------------
                          $66.64 - $95.20
Percentage Price Change = --------------- = (0.3)
                              $95.20

Excess Change = (0.3) + 0.2 = (0.1)

Adjusted Stock Consideration Amount = $54.60 + 1/2[$54.60 * (0.1)] = 
                                                       $54.60 + ($2.73) = $51.87

                 $51.87
Exchange Ratio = ------ = 0.77836
                 $66.64

- --------------------------------------------------------------------------------





         PRESS RELEASES

         For Release:  IMMEDIATELY

                    AEGON AND TRANSAMERICA CREATE ONE OF THE
                       LARGEST LIFE INSURERS IN THE U.S.
                    MARKET: COMBINING STRENGTH WITH STRENGTH

         THE HAGUE (THE NETHERLANDS), BALTIMORE, MARYLAND (U.S.) AND SAN
         FRANCISCO, CALIFORNIA (U.S.) -- AEGON N.V. (NYSE: AEG), the parent
         company of AEGON USA, Inc., and Transamerica Corporation (NYSE: TA),
         signed an agreement providing for AEGON's acquisition of Transamerica
         for cash and stock worth USD 9.7 billion. In addition, AEGON N.V. will
         assume on a consolidated basis approximately USD 1.1 billion of
         Transamerica's holding company debt. Transamerica's corporate and
         insurance operations will merge with AEGON USA's operations immediately
         after closing, which is expected to occur during the summer of 1999.
         The transaction is the second largest in the U.S. life insurance
         industry to date. Based on 1997 year-end figures, the combination of
         AEGON and Transamerica will result in the third largest life insurance
         group in the U.S. in terms of assets and premium written.

         The payment of the USD 9.7 billion transaction will be 70% in stock and
         30% in cash, representing a premium of 35.4% over New York's 17
         February 1999 closing price of USD 57 5/8 for a Transamerica share. The
         actual number of shares of AEGON N.V. will depend upon the
         determination of the average AEGON share price for the 20 trading days
         prior to the closing date of the transaction. The value of USD 9.7
         billion equals USD 78 per Transamerica share, of which USD 23.40 per
         share will be paid in cash. The USD 54.60 share value of the
         consideration paid in AEGON shares will remain fixed for a 20% increase
         or decrease in the AEGON share price of currently USD 95.20, between
         the date of signing and the date of closing. For the next 15% increase
         or decrease in the AEGON share price the effect of the increase or
         decrease will be shared equally between AEGON and Transamerica
         shareholders. Beyond a 35% positive or negative change in share price
         the affected parties can fix the exchange ratio at the 35% level,
         renegotiate or decide not to complete the transaction.
<PAGE>

         AEGON has priced this transaction to achieve an unleveraged return on
         equity of 9%, reflecting the lower cost of capital in today's
         environment. This is below AEGON's normal hurdle rate of 11% that will
         be maintained for the longer term. AEGON has maintained the same spread
         over risk free rates that existed at the time of the Providian
         transaction.

         It is expected that the positive effect on AEGON earnings per share in
         the years 1999 and 2000 will result in an additional increase in
         earnings per AEGON share of at least 3% in both years. In advance of
         the publication of its 1998 results on 3 March, AEGON's outlook for the
         full year 1999 is, assuming completion of the transaction at mid-year:
         barring unforeseen exceptional circumstances such as adverse currency
         and equity market movements and including the impact of Transamerica's
         acquisition, we expect an increase in 1999 earnings between 18% and 20%
         and in earnings per share between 12% and 15%.

         OPPORTUNITIES 
         AEGON USA and Transamerica, both major life insurance and pension
         providers in the USA, have complementary products and distribution
         channels. Following the transaction, the combined operations will have
         a more prominent position in the life insurance business and will be
         the second largest life reinsurer in the U.S., based on in force
         business. The addition of Transamerica's general agency distribution
         channel, which is focused on high net worth individuals, and
         Transamerica's Canadian operations, adds depth to AEGON USA's existing
         distribution. The combined operations will be a leading U.S. provider
         of long term care insurance products, insurance marketed at the
         worksite, GIC's, structured settlements and 401(k) pension plans. The
         acquisition will join Transamerica's well-established consumer brand
         name and franchise in the U.S. with AEGON USA's wide array of
         highly-ranked retirement and savings products and will unite both
         companies' successful management teams. Additionally, Transamerica has
         highly profitable and growing operations in commercial lending, leasing
         and real estate information services, which do not overlap with any
         AEGON USA businesses.


                                      -2-
<PAGE>

         The Transamerica businesses will find a stable platform for further
         enhancement of their market position by combining with AEGON USA. In
         addition to the growth opportunities that the transaction and combined
         activities present, the companies expect to be able to achieve
         approximately USD 150 million before tax in annual expense level
         reduction, including the combining of corporate functions, after a
         three year period.

         <TABLE>
         <CAPTION>
         KEY FIGURES
         (in million USD)                       TRANSAMERICA
                               TRANSAMERICA      INSURANCE         AEGON          AEGON
                                   CORP.           ONLY             USA            N.V.
                               1998             1998               1997           1997
         <S>                   <C>              <C>                <C>            <C>    
         Full year             US GAAP          USGAAP             Dutch          Principles
                                                                   Accounting
         Assets                58,503           46,186             63,691         135,205
         Total                 6,429            4,367              5,995          16,031
         revenues (not
         incl. annuities)
         Premium               1,847            1,847              3,285          10,756
         income
         Annuity/GIC           3,873            3,873              5,280          5,280
         deposits
         
         Note:  AEGON's 1998 figures will be published on 3 March 1999.
         </TABLE>
         
         CHAIRMEN'S STATEMENTS
         AEGON Chairman of the Executive Board Kees J. Storm said: "The
         acquisition of Transamerica strengthens our already impressive
         businesses in the United States and elevates us to a top three position
         in that country, based on 1997 statutory assets. AEGON has a proven
         track record of successfully integrating companies and people to create
         superior value. We believe that shareholders, policyholders and
         distributors of both companies will benefit from the great potential of
         the combined operation."

         Transamerica Chairman and CEO Frank C. Herringer said: "In a rapidly
         consolidating and globalizing financial services industry, this
         transaction unites Transamerica and its shareholders with one of the
         most financially strong and successful companies in the worldwide
         insurance industry. Furthermore, AEGON's and Transamerica's management
         teams have a well-earned reputation for their focus on shareholder
         value. We see this as a well-considered strategic move that will
         benefit customers, employees, shareholders and business partners."

         AEGON USA Chairman, President and CEO and member of AEGON N.V.'s
         Executive Board Donald J. Shepard said: "The ac-

                                      -3-
<PAGE>

         quisition of Transamerica, with its well-regarded brand name and
         franchise, simultaneously advances our objectives on a number of
         fronts. It offers us the ability to leverage our skills and financial
         strength into attractive new businesses; and it strengthens our
         distribution capabilities and product depth in key areas, enabling us
         to accelerate growth of our core operations. We look forward to working
         together with Transamerica's CEO Frank C. Herringer and his team of
         managers and employees."

         BACKGROUND INFORMATION
         AEGON is a leading international insurance group with its headquarters
         in The Hague, the Netherlands and is quoted on the stock exchanges of
         Amsterdam, New York (NYSE), London, Frankfurt, Zurich and Tokyo. AEGON
         has a major presence in five key markets: the USA, the Netherlands, the
         UK, Hungary and Spain.

         AEGON USA, headquartered in Baltimore, Maryland, operates through three
         groups: Agency, Alternative Markets and Pension. The separate divisions
         within each group operate as decentralized businesses targeting
         customers through focused marketing.

         Transamerica is a leading U.S. financial services company, whose shares
         are listed in New York (NYSE), at the Pacific Exchange, and in
         Amsterdam, London, Frankfurt, Paris and Switzerland. Transamerica is
         headquartered in San Francisco, California, and has life insurance
         operations in the U.S., Canada and Asia, and financial services
         businesses in the U.S. and throughout the world.

         FINANCING THE TRANSACTION
         Following the closing, Transamerica's shareholders in the aggregate
         will be entitled to AEGON common shares valued at approximately USD 6.8
         billion and USD 2.9 billion in cash. The actual number of shares will
         be based upon an average AEGON share price for the 20 trading days
         prior to the closing date. Approximately 80% of the AEGON shares
         required for the transaction will be newly issued New York registered
         shares, representing approximately a 10% increase in the total number
         of AEGON common shares outstanding. In addition, AEGON will purchase
         the remaining shares needed for the transaction from Vereniging AEGON
         (Association AEGON), AEGON's largest shareholder. Vereniging AEGON has
         also agreed to provide AEGON with a hedge, which will keep the purchase
         price of the shares approximately the same. Immediately preceding, and
         as a part of the agreement with Vereniging AEGON, new preferred shares
         will be issued to Vereniging AEGON, to maintain its majority voting
         rights in AEGON N.V. The transactions between 


                                      -4-
<PAGE>

         AEGON and Vereniging AEGON will be priced on an arms' length basis. The
         purchase of the common shares from Vereniging AEGON and the cash
         payment to Transamerica shareholders will be funded with excess capital
         and the proceeds from, as yet, unspecified capital market activities.

         VERENIGING AEGON
         Vereniging AEGON is an independent association, which has a voting
         majority in AEGON N.V. through its common and preferred share holdings.
         After completion of the transaction, Vereniging AEGON will buy common
         shares of AEGON N.V. in the open market with the aim to eventually
         regain a holding of approximately 40% of the common shares from the
         approximately 30% it is expected to hold immediately after the closing.
         Additional holdings will be accumulated gradually, so that extra
         volatility on the AEGON share price will be avoided as much as
         possible. Vereniging AEGON said it will refrain from market
         transactions in AEGON shares while this transaction is pending. The
         preferred shares to be issued will be gradually repurchased by AEGON
         N.V. as Vereniging AEGON regains its 40% holding of common shares.

         MANAGEMENT
         Frank C. Herringer will be invited to become a member of AEGON N.V.'s
         Executive Board. The Executive Board of AEGON N.V. would then consist
         of Kees J. Storm, chairman, Paul van de Geijn, Frank C. Herringer,
         Donald J. Shepard and Henk B. van Wijk. In the new combination - Frank
         C. Herringer will have line responsibilities for the commercial
         finance, leasing and real estate information operations, as well as
         responsibility for certain corporate functions and the further
         development of the Asia Pacific initiatives. Donald J. Shepard will
         continue to have line responsibilities for the combined insurance
         operations and related products in the U.S. and elsewhere in the
         Americas. The headquarters of the combined U.S. operation will be in
         San Francisco, California, although key executive and administrative
         functions will continue in their current locations. The Transamerica
         name and logo will be retained and be extended to the businesses of
         AEGON USA where appropriate.

         The transaction will be subject to customary conditions of closing,
         including receipt of the usual approvals of regulatory bodies as well
         as both parties' shareholders. The transaction has been approved by
         AEGON's Supervisory Board and an explanation of the transaction will be
         given at AEGON's Annual General Meeting of Shareholders on 29 April
         1999. The Central Works Council in the Netherlands has reacted
         positively.

                                      -5-
<PAGE>

         The Hague, Baltimore, 18 February 1999 / San Francisco, 17 February
         1999

         --------------------------------------------------------------------


<TABLE>
<CAPTION>
         INQUIRIES:

         <S>                       <C>                            <C>    
         AEGON USA, Inc.           AEGON N.V.                     Transamerica Corp.
         Press and Public          Group Communications           Communications
         Relations                 + 31 70 344 83 44              + 1 415 983 40 87
         + 1 410 576 45 76

         + 1 502 560 21 67         Investor Relations             Investor Relations
                                   + 31 70 344 83 05              + 1 415 983 55 03

         Attachments:              Profile AEGON N.V.
                                   Profile AEGON USA, Inc.
                                   Profile Transamerica Corp.
                                   Profile Vereniging AEGON
</TABLE>


         
         -----------------------------------------------------------------------
         As mentioned previously, the actual number of shares of AEGON N.V.
         required for this transaction may vary depending upon the determination
         of the average AEGON share price at the time of closing. Transamerica
         shareholders will have the right to AEGON N.V. stock with a value of
         USD 54.60 per Transamerica share, subject to adjustment if the average
         AEGON share price over a specified period of time prior to the closing
         exceeds USD 114.24 or is less than USD 76.16. In addition, to the
         extent that the average AEGON share price is less than USD 61.88 or
         more than USD 128.52, the agreement may be terminated unless the
         parties agree to further adjust the number of shares of AEGON N.V.
         stock to be received by Transamerica shareholders.

         A registration statement relating to the common stock to be issued in
         connection with the transaction has not yet been filed with the
         Securities and Exchange Commission, nor has a proxy statement relating
         to a vote of the stockholders on the transaction been filed with the
         Securities and Exchange Commission. The common stock may not be
         offered, nor may offers to acquire such stock be accepted, prior to the
         time such registration statement becomes effective. This press release
         shall not constitute an offer to sell or the solicitation of an offer
         to buy any common stock or any other security, and shall not constitute
         the solicitation of any vote with respect to the transaction.
         -----------------------------------------------------------------------


         PROFILE AEGON N.V.

         The AEGON Group has grown to become one of the world's leading
         international insurance groups. Headquartered in The Hague in the
         Netherlands, with assets totaling over USD 147 billion, approximately
         86% of AEGON's business is life insurance, pensions and 

                                      -6-
<PAGE>

         related savings and investment products. The remainder is in health
         insurance and property and casualty insurance. With core operations in
         the USA, the Netherlands, the United Kingdom, Hungary and Spain, AEGON
         has five highly concentrated, sizable national units. Each unit is a
         major competitor in its local market.

         STRATEGY
         AEGON operates as a 'multi-domestic' organization: highly
         decentralized, locally managed business units frequently utilize local
         brand names rather than the AEGON brand name. The Group has strong
         emphasis on autonomous growth of its existing operations. Second come
         selective acquisitions in countries where AEGON already has a presence.
         In addition, the Group takes a very disciplined approach to further
         internationalization into other geographic areas. In evaluating new
         business ventures, appropriate ROI hurdles are applied, taking into
         account the likely volatility of returns from the proposed investment.
         AEGON has a clear emphasis on profitability and the Group focuses on
         its core business, which is insurance, particularly life insurance,
         pensions, savings and investment products.

         ACTIVITIES
         AEGON USA markets life and health insurance and annuity and investment
         products. Each division specializes in a selected segment of the market
         in which it has experience and knowledge of its customers' needs. AEGON
         The Netherlands is active in both the life and non-life insurance
         market and is the second largest provider of life insurance with in the
         Netherlands a market share in group life of 20% and 12% in individual
         life. It operates primarily through independent intermediaries. AEGON
         UK in the United Kingdom is an acknowledged leader in the market for
         pensions distributed through IFAs. It also provides asset management
         services and markets third party investment management products.
         AB-AEGON in Hungary offers a wide range of life and non-life products
         through its own sales force and via professional intermediaries. AEGON
         Spain offers individual and business customers specialized life and
         non-life products through independent agents mainly. The AEGON Group is
         also active in Belgium, Germany, Mexico, the Philippines and Taiwan and
         has representative offices in China and India.

         RANKINGS
         Ranked by market capitalization AEGON is the world's third largest
         listed insurance group.

                                      -7-
<PAGE>

         PROFILE AEGON USA

         AEGON USA, headquartered in Baltimore, Maryland, accounts for over
         fifty percent of AEGON's pre-tax income. Offering life and health
         insurance and savings and retirement products, AEGON USA operates
         through three groups: Agency, Alternative Markets and Pension. The
         separate divisions in each group operate as independent businesses
         targeting customers through focused marketing.

         AGENCY GROUP
         The EQUITY GROUP in St. Petersburg, Florida offers variable insurance
         products and mutual funds through independent agents and other third
         parties. 
         The INDIVIDUAL DIVISION in Cedar Rapids, Iowa offers traditional life
         insurance, mutual funds, accident and health coverage and annuity
         products through independent agents. 
         The MONUMENTAL LIFE DIVISION in Baltimore, Maryland offers traditional
         insurance products through career and independent agents.

         ALTERNATIVE MARKETS GROUP
         The FINANCIAL MARKETS DIVISION in Cedar Rapids, Iowa, offers fixed and
         variable annuity and life insurance products through banks and other
         financial institutions. 
         The LONG TERM CARE DIVISION in Bedford, Texas, offers long-term care
         insurance products through marketing organizations, independent agents
         and brokers. 
         The SPECIAL MARKETS GROUP in Baltimore, Maryland, offers life,
         supplemental health, credit and mortgage insurance products through
         direct marketing channels. 
         The WORKSITE MARKETING DIVISION in Little Rock, Arkansas, offers
         supplementary life and health insurance products through employer
         payroll deduction.

         PENSION GROUP
         DIVERSIFIED FINANCIAL PRODUCTS in Louisville, Kentucky, offers
         guaranteed savings and investment products sold directly to
         institutional retirement and investment markets. 
         DIVERSIFIED INVESTMENT ADVISORS in Purchase, New York, offers
         retirement plan investments and services for mid- and large-size
         companies, state and local governments and non-profit organizations.

                                      -8-
<PAGE>

         PROFILE TRANSAMERICA CORPORATION

         Transamerica, headquartered in San Francisco, is a financial services
         company with approximately USD 58.5 billion in assets. The company's
         two major business lines are life insurance and finance.

         LIFE INSURANCE
         The Transamerica Life Companies are headquartered in Los Angeles,
         California with major operations in Charlotte, North Carolina; Kansas
         City, Missouri; Purchase, New York and Toronto, Canada. Transamerica
         Life is the sixth largest life insurer in North America based on life
         insurance in force, and one of the top life reinsurers in the U.S.
         based on new business and in force volume.

         The Life Companies design, underwrite and service life insurance,
         annuities, long term care insurance and other financial security
         products that are sold in the U.S., Canada and Asia through general
         agencies, banks, broker/dealers and special distributors and by
         independent agents and financial planners. Transamerica Life also
         provides reinsurance, risk management consulting and product
         development services, and develops, manages and sells mutual funds,
         retirement plans and other investment products such as investment
         contracts for stable value funds, municipalities and structured
         settlements.

         FINANCE
         Commercial Lending: Transamerica Commercial Finance is based in the
         Chicago, Illinois area. It is one of the largest independent commercial
         lending operations in the U.S., based on net finance receivables owned
         and serviced. Transamerica Commercial Finance makes commercial loans
         through three operations. Transamerica Distribution Finance provides
         financing for manufacturers, distributors, retailers and consumers in a
         wide range of industries. Transamerica Business Credit makes loans to
         many types of businesses for a variety of needs. Transamerica Equipment
         Financial Services provides equipment financing through loans and
         leases to a wide variety of businesses and municipal entities.

         Leasing: Transamerica Leasing is headquartered in Purchase, New York.
         Its container fleet is the largest in the industry. The company leases,
         manages and provides financing for intermodal transportation equipment
         around the world. Its fleet includes standard containers, specialized
         containers such as refrigerated and tank containers, rail trailers and
         chassis.

                                      -9-
<PAGE>

         Real Estate Services: The Transamerica Real Estate Information
         Companies are headquartered in Dallas, Texas. Transamerica Real Estate
         Tax Service is the nation's largest servicer of mortgage loans. The
         company obtains property tax information, monitors property payments
         and provides tax payment processing. Transamerica Flood Hazard
         Certification offers flood hazard determination services. Transamerica
         Intellitech markets real estate information software.


         PROFILE 'VERENIGING AEGON' (ASSOCIATION AEGON)

         The association 'Vereniging AEGON' is the continuation of the former
         AGO mutual life insurance company. After a restructuring in the
         seventies, the insurance activities of the AGO group were held by AGO
         Holding N.V. and the unlisted shares in AGO Holding N.V. were held by
         the association. AGO Holding merged with the listed insurance company
         ENNIA in 1983 and thus formed AEGON N.V. As a consequence Vereniging
         AEGON now owns shares in AEGON N.V. The cooperation of Vereniging AEGON
         optimizes the funding of the proposed transaction. It also eliminates
         possible substantial financial downside risks involved for AEGON.

         According to the articles of association of Vereniging AEGON its
         primary purpose is to promote the interests of the companies forming
         part of or are associated with the AEGON Group as well as those of
         policyholders, employees, shareholders and other parties associated
         with the AEGON Group. In accordance with the 1983 AEGON merger
         agreement Vereniging AEGON is entitled to newly issued preferred shares
         in the event that it would lose its majority voting rights in AEGON
         N.V. For this reason Vereniging AEGON requested the issue of new
         preferred shares which secure these rights.





                                      -10-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission